{"content": "Protocols Three mm cores removed formalin fixed paraffin embedded tissue blocks","annotation":[{"label":["Cell type/tissue"],"points":[{"start":66,"end":78,"text":"tissue blocks"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":65,"text":"Protocols Three mm cores removed formalin fixed paraffin embedded "}]}],"extras":null,"metadata":{"first_done_at":1542137269000,"last_updated_at":1542137269000,"sec_taken":21,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "NK cells flow sorted resting C57Bl 6 mouse spleens gt","annotation":[{"label":["Cell type/tissue"],"points":[{"start":43,"end":52,"text":"spleens gt"}]},{"label":["Genotype"],"points":[{"start":28,"end":41,"text":" C57Bl 6 mouse"}]},{"label":["Treatment and conditions"],"points":[{"start":8,"end":19,"text":" flow sorted"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":7,"text":"NK cells"}]}],"extras":null,"metadata":{"first_done_at":1542150344000,"last_updated_at":1542150344000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "activated NK cells stimulated rmIL 15 24 hours prior lysis RNA isolation","annotation":[{"label":["Treatment and conditions"],"points":[{"start":19,"end":71,"text":"stimulated rmIL 15 24 hours prior lysis RNA isolation"}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":17,"text":"NK cells"}]}],"extras":null,"metadata":{"first_done_at":1542155298000,"last_updated_at":1542155298000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols 100 mcg chromatin isolated purified nuclei adult mouse pancreas","annotation":[{"label":["Cell type/tissue"],"points":[{"start":46,"end":72,"text":"nuclei adult mouse pancreas"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":72,"text":"Protocols 100 mcg chromatin isolated purified nuclei adult mouse pancreas"}]}],"extras":null,"metadata":{"first_done_at":1542158017000,"last_updated_at":1542158017000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "6 mcg affinity purified rabbit anti mouse Ptf1a 7","annotation":[{"label":["Genotype"],"points":[{"start":42,"end":48,"text":"Ptf1a 7"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":40,"text":"6 mcg affinity purified rabbit anti mouse"}]}],"extras":null,"metadata":{"first_done_at":1542155261000,"last_updated_at":1542155261000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "ES cells plated onto laminin coated plates N2B27 media density 100","annotation":[{"label":["Treatment and conditions"],"points":[{"start":21,"end":65,"text":"laminin coated plates N2B27 media density 100"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":7,"text":"ES cells"}]}],"extras":null,"metadata":{"first_done_at":1542136892000,"last_updated_at":1542136892000,"sec_taken":94,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Libraries prepared NEXTflex Rapid Directional Illumina RNA seq Library Prep Kit Bioo Scientific","annotation":[{"label":["Geographical Location"],"points":[{"start":80,"end":94,"text":"Bioo Scientific"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":78,"text":"Libraries prepared NEXTflex Rapid Directional Illumina RNA seq Library Prep Kit"}]}],"extras":null,"metadata":{"first_done_at":1542151168000,"last_updated_at":1542151168000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "GMP cultured 2 days serum free medium rmSCF rmFlt3L 50ng ml followed 2 days IMDM 10 FCS rmSCF 50ng ml","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":100,"text":"GMP cultured 2 days serum free medium rmSCF rmFlt3L 50ng ml followed 2 days IMDM 10 FCS rmSCF 50ng ml"}]}],"extras":null,"metadata":{"first_done_at":1542149832000,"last_updated_at":1542149832000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols RNA tissues isolated modified guanidium thiocynate methods followed polyA RNA selection two rounds oligo dT cellulose columns","annotation":[{"label":["Treatment and conditions"],"points":[{"start":40,"end":134,"text":"guanidium thiocynate methods followed polyA RNA selection two rounds oligo dT cellulose columns"}]},{"label":["Cell type/tissue"],"points":[{"start":14,"end":29,"text":"tissues isolated"}]}],"extras":null,"metadata":{"first_done_at":1542148779000,"last_updated_at":1542148779000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Cell lines grown standard conditions DMEM supplemented 10 v v bovine calf serum Gibco BRL Transfections small interfering RNAs siRNAs carried 6 12 well plates using jetPRIME Polyplus according manufacturer recommendations","annotation":[{"label":["Treatment and conditions"],"points":[{"start":100,"end":230,"text":"Transfections small interfering RNAs siRNAs carried 6 12 well plates using jetPRIME Polyplus according manufacturer recommendations"}]},{"label":["Genotype"],"points":[{"start":90,"end":99,"text":"Gibco BRL "}]},{"label":["Species"],"points":[{"start":72,"end":82,"text":"bovine calf"}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":19,"text":"Cell lines"}]}],"extras":null,"metadata":{"first_done_at":1542140118000,"last_updated_at":1542140131000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "PolyA library selection performed using NEBNext poly A mRNA magnetic isolation module E7490L according manufacturer specifications","annotation":null,"extras":null,"metadata":{"first_done_at":1542159637000,"last_updated_at":1542159637000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "adult NSCs allowed recover overnight prior transduction Total RNA isolated using RNAeasy Plus Micro kit Qiagen 150 250 ng RNA used library construction","annotation":[{"label":["Treatment and conditions"],"points":[{"start":37,"end":150,"text":"prior transduction Total RNA isolated using RNAeasy Plus Micro kit Qiagen 150 250 ng RNA used library construction"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":9,"text":"adult NSCs"}]}],"extras":null,"metadata":{"first_done_at":1542149647000,"last_updated_at":1542149647000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Ribosomal RNA removed using Ribo Zero Magnetic Kit Epicentre","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":59,"text":"Ribosomal RNA removed using Ribo Zero Magnetic Kit Epicentre"}]}],"extras":null,"metadata":{"first_done_at":1542149676000,"last_updated_at":1542149676000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "A tumor cell line derived injected cells underwent gene amplification detected focal peak WGS analysis","annotation":[{"label":["Genotype"],"points":[{"start":51,"end":69,"text":"gene amplification "}]},{"label":["Cell type/tissue"],"points":[{"start":2,"end":16,"text":"tumor cell line"}]}],"extras":null,"metadata":{"first_done_at":1542151877000,"last_updated_at":1542151877000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols NS5 cells cultured previously described Conti et al","annotation":[{"label":["Treatment and conditions"],"points":[{"start":20,"end":60,"text":"cultured previously described Conti et al"}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":18,"text":"NS5 cells"}]}],"extras":null,"metadata":{"first_done_at":1542138986000,"last_updated_at":1542138986000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "000 cm2 NS5 cells fixed sequentially di N succimidyl glutarate 1 formaldehyde phosphate buffered saline lysed","annotation":[{"label":["Treatment and conditions"],"points":[{"start":18,"end":108,"text":"fixed sequentially di N succimidyl glutarate 1 formaldehyde phosphate buffered saline lysed"}]},{"label":["Cell type/tissue"],"points":[{"start":8,"end":16,"text":"NS5 cells"}]}],"extras":null,"metadata":{"first_done_at":1542139341000,"last_updated_at":1542139341000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "rabbit anti RBPJ DNA libraries prepared 10ng immunoprecipitated DNA according standard Illumina ChIP seq protocol","annotation":[{"label":["Treatment and conditions"],"points":[{"start":7,"end":112,"text":"anti RBPJ DNA libraries prepared 10ng immunoprecipitated DNA according standard Illumina ChIP seq protocol"}]}],"extras":null,"metadata":{"first_done_at":1542149295000,"last_updated_at":1542149295000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Cell culture protocol Extraction DNA ID8 cells Exome capture using Agilent SureSelect Target Enrichment Illumina Paired end Multiplex Sequencing","annotation":[{"label":["Cell type/tissue"],"points":[{"start":47,"end":55,"text":"ID8 cells"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":153,"text":"Protocols Cell culture protocol Extraction DNA ID8 cells Exome capture using Agilent SureSelect Target Enrichment Illumina Paired end Multiplex Sequencing"}]}],"extras":null,"metadata":{"first_done_at":1542157657000,"last_updated_at":1542157657000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "human bile duct tumor Opisthorchis viverrini related cholangiocarcinoma CCA patient paired tumor set 1","annotation":[{"label":["Species"],"points":[{"start":22,"end":43,"text":"Opisthorchis viverrini"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":101,"text":"human bile duct tumor Opisthorchis viverrini related cholangiocarcinoma CCA patient paired tumor set 1"}]}],"extras":null,"metadata":{"first_done_at":1542143049000,"last_updated_at":1542143049000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Primary human hepatocytes PHH exposed daily 5 days 15 mM VPA DNA isolated","annotation":[{"label":["Treatment and conditions"],"points":[{"start":40,"end":82,"text":"exposed daily 5 days 15 mM VPA DNA isolated"}]},{"label":["Cell type/tissue"],"points":[{"start":18,"end":82,"text":"human hepatocytes PHH exposed daily 5 days 15 mM VPA DNA isolated"}]}],"extras":null,"metadata":{"first_done_at":1542148904000,"last_updated_at":1542148904000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "methylated DNAs size selected ligated sequencing following TruSeqTM SBS Kit v3 paired end sequencing synthesis SBS","annotation":null,"extras":null,"metadata":{"first_done_at":1542153101000,"last_updated_at":1542153101000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Reference Hypoxia fate mapping identifies cycling cardiomyocytes adult heart","annotation":[{"label":["Cell type/tissue"],"points":[{"start":42,"end":75,"text":"cycling cardiomyocytes adult heart"}]},{"label":["Treatment and conditions"],"points":[{"start":10,"end":21,"text":"Hypoxia fate"}]}],"extras":null,"metadata":{"first_done_at":1542155048000,"last_updated_at":1542155048000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "All RNA subsequently quantified UV Vis spectrophotometer visualized quality using RNA integrity analysis","annotation":[{"label":["Treatment and conditions"],"points":[{"start":21,"end":55,"text":"quantified UV Vis spectrophotometer"}]}],"extras":null,"metadata":{"first_done_at":1542140877000,"last_updated_at":1542140877000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Nucleosomes identified Mnase digestion followed direct sequencing human CD T cells activated anti CD3 anti CD28 antibodies 18 hr","annotation":[{"label":["Cell type/tissue"],"points":[{"start":66,"end":81,"text":"human CD T cells"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":38,"text":"Nucleosomes identified Mnase digestion "}]}],"extras":null,"metadata":{"first_done_at":1542136798000,"last_updated_at":1542136798000,"sec_taken":49,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "VEGF amplified genomic DNA isolated HEK293 cells treated wild type Cas9 two sgRNAs spaced 19 bp apart targeting CLTA site","annotation":[{"label":["Genotype"],"points":[{"start":57,"end":65,"text":"wild type"}]},{"label":["Cell type/tissue"],"points":[{"start":36,"end":47,"text":"HEK293 cells"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":120,"text":"VEGF amplified genomic DNA isolated HEK293 cells treated wild type Cas9 two sgRNAs spaced 19 bp apart targeting CLTA site"}]}],"extras":null,"metadata":{"first_done_at":1542159625000,"last_updated_at":1542159625000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "two sgRNAs spaced 23 bp apart targeting EMX site","annotation":[{"label":["Genotype"],"points":[{"start":11,"end":47,"text":"spaced 23 bp apart targeting EMX site"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":47,"text":"two sgRNAs spaced 23 bp apart targeting EMX site"}]}],"extras":null,"metadata":{"first_done_at":1542152803000,"last_updated_at":1542152803000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Four individual ChIPs pooled precipitated DNA purified using Qiaquick columns Qiagen","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":83,"text":"Four individual ChIPs pooled precipitated DNA purified using Qiaquick columns Qiagen"}]}],"extras":null,"metadata":{"first_done_at":1542150872000,"last_updated_at":1542150872000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "gondii infection 10 days post infection peak chronic infection 28 days post infection","annotation":[{"label":["Disease state"],"points":[{"start":40,"end":62,"text":"peak chronic infection "}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":84,"text":"gondii infection 10 days post infection peak chronic infection 28 days post infection"}]}],"extras":null,"metadata":{"first_done_at":1542155081000,"last_updated_at":1542155081000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols MCF10A cells cultured DMEM F12 media supplemented 2","annotation":[{"label":["Treatment and conditions"],"points":[{"start":23,"end":60,"text":"cultured DMEM F12 media supplemented 2"}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":21,"text":"MCF10A cells"}]}],"extras":null,"metadata":{"first_done_at":1542156629000,"last_updated_at":1542156629000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "HT 29 cells cultured RPMI1640 McCoy 5A medium supplemented 10 fetal bovine serum","annotation":[{"label":["Treatment and conditions"],"points":[{"start":12,"end":79,"text":"cultured RPMI1640 McCoy 5A medium supplemented 10 fetal bovine serum"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":10,"text":"HT 29 cells"}]}],"extras":null,"metadata":{"first_done_at":1542152285000,"last_updated_at":1542152285000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "culture medium replaced fresh medium plus drug 24 h initiation incubation","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":72,"text":"culture medium replaced fresh medium plus drug 24 h initiation incubation"}]}],"extras":null,"metadata":{"first_done_at":1542157589000,"last_updated_at":1542157589000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Single step method RNA isolation acid guanidinium thiocyanate phenol chloroform extraction","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":89,"text":"Single step method RNA isolation acid guanidinium thiocyanate phenol chloroform extraction"}]}],"extras":null,"metadata":{"first_done_at":1542138220000,"last_updated_at":1542138220000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Dissociated cells human gallbladder cystic duct cultured rat mammary feeder culture using modified culture medium published PMID 23562832","annotation":[{"label":["Treatment and conditions"],"points":[{"start":48,"end":136,"text":"cultured rat mammary feeder culture using modified culture medium published PMID 23562832"}]},{"label":["Disease state"],"points":[{"start":36,"end":46,"text":"cystic duct"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":34,"text":"Dissociated cells human gallbladder"}]}],"extras":null,"metadata":{"first_done_at":1542139128000,"last_updated_at":1542139128000,"sec_taken":116,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Genetic analysis performed frozen fragments stored 80 C Neurobiotec Bank","annotation":[{"label":["Geographical Location"],"points":[{"start":56,"end":71,"text":"Neurobiotec Bank"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":54,"text":"Genetic analysis performed frozen fragments stored 80 C"}]}],"extras":null,"metadata":{"first_done_at":1542150507000,"last_updated_at":1542150507000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "PMID 16688168 treated 6ug ml polyI C Invivogen Qiazol protocol according manual Truseq kit Illumina","annotation":null,"extras":null,"metadata":{"first_done_at":1542158069000,"last_updated_at":1542158069000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Extensive research LNCaP progression cell model advanced understanding generation lethal phenotype","annotation":[{"label":["Genotype"],"points":[{"start":82,"end":97,"text":"lethal phenotype"}]},{"label":["Cell type/tissue"],"points":[{"start":19,"end":40,"text":"LNCaP progression cell"}]}],"extras":null,"metadata":{"first_done_at":1542151606000,"last_updated_at":1542151625000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "performed RNA Seq characterize genome wide expression patterns alternative splicing events androgen dependent LNCaP independent LNCaP AI F","annotation":null,"extras":null,"metadata":{"first_done_at":1542155819000,"last_updated_at":1542155819000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Silastic tubing containing 35 ul oil 35ul oil 180ug ml E2","annotation":[{"label":["Treatment and conditions"],"points":[{"start":10,"end":66,"text":"Silastic tubing containing 35 ul oil 35ul oil 180ug ml E2"}]}],"extras":null,"metadata":{"first_done_at":1542136590000,"last_updated_at":1542136590000,"sec_taken":47,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Total RNA extracted using Ambion RNAqueous according manufacturers protocol","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":74,"text":"Total RNA extracted using Ambion RNAqueous according manufacturers protocol"}]}],"extras":null,"metadata":{"first_done_at":1542140848000,"last_updated_at":1542140848000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Human primary islets purchased Prodo Laboratories Inc Irvine","annotation":[{"label":["Geographical Location"],"points":[{"start":41,"end":69,"text":"Prodo Laboratories Inc Irvine"}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":29,"text":"Human primary islets"}]}],"extras":null,"metadata":{"first_done_at":1542158683000,"last_updated_at":1542158683000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Swizerland Illumina TruSeq Stranded mRNA Library prep kit following manufacturer recommendations","annotation":[{"label":["Geographical Location"],"points":[{"start":0,"end":9,"text":"Swizerland"}]}],"extras":null,"metadata":{"first_done_at":1542153095000,"last_updated_at":1542153095000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Germinal vesicle GV metaphase I MI oocytes n 79 obtained healthy female patients ages 26 43 undergoing vitro fertilization treatment","annotation":[{"label":["Treatment and conditions"],"points":[{"start":92,"end":131,"text":"undergoing vitro fertilization treatment"}]},{"label":["Disease state"],"points":[{"start":57,"end":84,"text":"healthy female patients ages"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":42,"text":"Germinal vesicle GV metaphase I MI oocytes "}]}],"extras":null,"metadata":{"first_done_at":1542149518000,"last_updated_at":1542149518000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Cells fractionated nuclear RNA extracted using Paris Kit Life technologies according manufacturer instructions","annotation":[{"label":["Geographical Location"],"points":[{"start":47,"end":73,"text":"Paris Kit Life technologies"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":39,"text":"Cells fractionated nuclear RNA extracted"}]}],"extras":null,"metadata":{"first_done_at":1542149958000,"last_updated_at":1542149958000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "mRNA Seq libraries polyA cytoplasmic RNA created according standard Illumina TruSeq protocol","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":91,"text":"mRNA Seq libraries polyA cytoplasmic RNA created according standard Illumina TruSeq protocol"}]}],"extras":null,"metadata":{"first_done_at":1542136680000,"last_updated_at":1542136680000,"sec_taken":47,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "4 control 5 AD cases brain bank Emory University selected RNAseq","annotation":null,"extras":null,"metadata":{"first_done_at":1542157800000,"last_updated_at":1542157800000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The white blood cell population col Hi C performed following Lieberman Aiden et al","annotation":[],"extras":null,"metadata":{"first_done_at":1542157508000,"last_updated_at":1542157508000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "For CHiC experiments promoter interactions enriched using biotynilated RNA bait library described","annotation":null,"extras":null,"metadata":{"first_done_at":1542155775000,"last_updated_at":1542155775000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "library preparation 454 technology sequencing performed parallel library exosome like vesicles","annotation":null,"extras":null,"metadata":{"first_done_at":1542156231000,"last_updated_at":1542156231000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "All sequence reads mapped reference human genome UCSC hg 19 using Illumina Pipeline software version 1","annotation":null,"extras":null,"metadata":{"first_done_at":1542157870000,"last_updated_at":1542157870000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Five six weeks old BALB cAJcl nu nu female nude mice CLEA Japan","annotation":[{"label":["Geographical Location"],"points":[{"start":58,"end":62,"text":"Japan"}]},{"label":["Genotype"],"points":[{"start":19,"end":56,"text":"BALB cAJcl nu nu female nude mice CLEA"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":17,"text":"Five six weeks old"}]}],"extras":null,"metadata":{"first_done_at":1542143656000,"last_updated_at":1542143656000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Mice high low total fecal IgA two separate specific pathogen free facilities compared 16S sequencing fecal material","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":114,"text":"Mice high low total fecal IgA two separate specific pathogen free facilities compared 16S sequencing fecal material"}]}],"extras":null,"metadata":{"first_done_at":1542157347000,"last_updated_at":1542157347000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The library quantified using KAPA library quantification kit Illumina sequencing platforms KK4824","annotation":null,"extras":null,"metadata":{"first_done_at":1542155193000,"last_updated_at":1542155193000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "This individual 69 year old male South Asian origin Country Birth India","annotation":[{"label":["Geographical Location"],"points":[{"start":33,"end":70,"text":"South Asian origin Country Birth India"}]},{"label":["Treatment and conditions"],"points":[{"start":5,"end":31,"text":"individual 69 year old male"}]}],"extras":null,"metadata":{"first_done_at":1542151987000,"last_updated_at":1542151987000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Using 4C sequencing determined genomic elements interact EVI1 GATA2 promoter","annotation":[{"label":["Genotype"],"points":[{"start":57,"end":75,"text":"EVI1 GATA2 promoter"}]}],"extras":null,"metadata":{"first_done_at":1542150987000,"last_updated_at":1542150987000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "We determined native GATA2 enhancer interacts EVI1 promoter repositioning mediated inv 3 q21q26 3","annotation":[{"label":["Genotype"],"points":[{"start":82,"end":96,"text":" inv 3 q21q26 3"}]},{"label":["Treatment and conditions"],"points":[{"start":60,"end":81,"text":"repositioning mediated"}]},{"label":["Genotype"],"points":[{"start":21,"end":59,"text":"GATA2 enhancer interacts EVI1 promoter "}]}],"extras":null,"metadata":{"first_done_at":1542142677000,"last_updated_at":1542142677000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Cg Tg Ins1 EGFP 1Hara J crossed CD1 females obtain embryo mice desired ages","annotation":[{"label":["Treatment and conditions"],"points":[{"start":63,"end":74,"text":"desired ages"}]},{"label":["Cell type/tissue"],"points":[{"start":44,"end":56,"text":"obtain embryo"}]},{"label":["Genotype"],"points":[{"start":0,"end":35,"text":"Cg Tg Ins1 EGFP 1Hara J crossed CD1 "}]}],"extras":null,"metadata":{"first_done_at":1542148661000,"last_updated_at":1542148661000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "5 pancreatic tissues dissociated trypsin 37 C 10 60 minutes","annotation":[{"label":["Treatment and conditions"],"points":[{"start":21,"end":39,"text":"dissociated trypsin"}]},{"label":["Cell type/tissue"],"points":[{"start":2,"end":19,"text":"pancreatic tissues"}]}],"extras":null,"metadata":{"first_done_at":1542140352000,"last_updated_at":1542140352000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Flow Cytometry experiments performed VMC Flow Cytometry Shared Resource BD Aria I II","annotation":[{"label":["Geographical Location"],"points":[{"start":37,"end":83,"text":"VMC Flow Cytometry Shared Resource BD Aria I II"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":36,"text":"Flow Cytometry experiments performed "}]}],"extras":null,"metadata":{"first_done_at":1542139498000,"last_updated_at":1542139498000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Assay capture sequence rearranged genomic DNA TC Seq mouse B Cells 53BP1 AID double strand breaks induced c myc chromosome 15 loci","annotation":[{"label":["Genotype"],"points":[{"start":106,"end":129,"text":"c myc chromosome 15 loci"}]},{"label":["Treatment and conditions"],"points":[{"start":67,"end":104,"text":"53BP1 AID double strand breaks induced"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":65,"text":"Assay capture sequence rearranged genomic DNA TC Seq mouse B Cells"}]}],"extras":null,"metadata":{"first_done_at":1542143117000,"last_updated_at":1542143117000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Fresh frozen breast tissue samples obtained women surgery Huntsman Cancer Hospital 2009 2012 RNA libraries made Illumina TruSeq Stranded mRNA Sample Preparation kit oligo dT selection according manufacturer protocol","annotation":[{"label":["Geographical Location"],"points":[{"start":68,"end":91,"text":"Huntsman Cancer Hospital"}]},{"label":["Treatment and conditions"],"points":[{"start":45,"end":66,"text":"obtained women surgery"}]},{"label":["Cell type/tissue"],"points":[{"start":23,"end":44,"text":"breast tissue samples "}]}],"extras":null,"metadata":{"first_done_at":1542138015000,"last_updated_at":1542138015000,"sec_taken":67,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The bone biopsy taken Tyrolean Iceman left ilium sterile conditions Iceman preservation cell South Tyrol Archaeological Museum Bolzano","annotation":[{"label":["Geographical Location"],"points":[{"start":93,"end":103,"text":"South Tyrol"}]},{"label":["Treatment and conditions"],"points":[{"start":49,"end":66,"text":"sterile conditions"}]},{"label":["Cell type/tissue"],"points":[{"start":38,"end":47,"text":"left ilium"}]},{"label":["Cell type/tissue"],"points":[{"start":4,"end":20,"text":"bone biopsy taken"}]}],"extras":null,"metadata":{"first_done_at":1542150219000,"last_updated_at":1542150219000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Library preparation performed using TruSeq Nano DNA kit Illumina target insert size 350bp","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":88,"text":"Library preparation performed using TruSeq Nano DNA kit Illumina target insert size 350bp"}]}],"extras":null,"metadata":{"first_done_at":1542140697000,"last_updated_at":1542140760000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Paired end libraries 150bp sequenced using HiSeqX sequencer Illumina","annotation":null,"extras":null,"metadata":{"first_done_at":1542159247000,"last_updated_at":1542159247000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "AW8507 lines maintained DMEM media Exome enrichment performed using manufactureras protocol Illumina TruSeq exome enrichment kit","annotation":[{"label":["Geographical Location"],"points":[{"start":68,"end":81,"text":"manufactureras"}]},{"label":["Treatment and conditions"],"points":[{"start":13,"end":60,"text":"maintained DMEM media Exome enrichment performed"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":11,"text":"AW8507 lines"}]}],"extras":null,"metadata":{"first_done_at":1542151551000,"last_updated_at":1542151568000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "PDGFRb positive cells meninges tissue grown suspension cultures PDGFRb neurospheres","annotation":[{"label":["Treatment and conditions"],"points":[{"start":38,"end":82,"text":"grown suspension cultures PDGFRb neurospheres"}]},{"label":["Cell type/tissue"],"points":[{"start":22,"end":36,"text":"meninges tissue"}]},{"label":["Genotype"],"points":[{"start":0,"end":14,"text":"PDGFRb positive"}]}],"extras":null,"metadata":{"first_done_at":1542138344000,"last_updated_at":1542138344000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Frozen brain tissue prefrontal cortex Brodmann Area 9 BA9 obtained stored 80 degree refrigerator Total RNA samples isolated using QIAzol Lysis Reagent purified using miRNeasy MinElute Cleanup columns Qiagen Sciences Inc","annotation":[{"label":["Geographical Location"],"points":[{"start":210,"end":228,"text":"Qiagen Sciences Inc"}]},{"label":["Treatment and conditions"],"points":[{"start":68,"end":209,"text":"obtained stored 80 degree refrigerator Total RNA samples isolated using QIAzol Lysis Reagent purified using miRNeasy MinElute Cleanup columns "}]},{"label":["Cell type/tissue"],"points":[{"start":17,"end":46,"text":"brain tissue prefrontal cortex"}]}],"extras":null,"metadata":{"first_done_at":1542137795000,"last_updated_at":1542137795000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "This study performed investigate global gene expression profile distinct subpopulations MS1","annotation":[{"label":["Cell type/tissue"],"points":[{"start":72,"end":90,"text":" subpopulations MS1"}]}],"extras":null,"metadata":{"first_done_at":1542140167000,"last_updated_at":1542140167000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Whole saliva contains least two types exosomes exosome I exosome II thatare different size protein composition","annotation":[{"label":["Genotype"],"points":[{"start":28,"end":109,"text":"two types exosomes exosome I exosome II thatare different size protein composition"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":11,"text":"Whole saliva"}]}],"extras":null,"metadata":{"first_done_at":1542156522000,"last_updated_at":1542156522000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "RNA isolated RNeasy kit Qiagen PolyA RNA isolated using Dynabeads mRNA purification kit Invitrogen","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":97,"text":"RNA isolated RNeasy kit Qiagen PolyA RNA isolated using Dynabeads mRNA purification kit Invitrogen"}]}],"extras":null,"metadata":{"first_done_at":1542143601000,"last_updated_at":1542143601000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "cDNA library prepared validated using Illumina TruSeq RNA sample preparation kit v2","annotation":[{"label":["Geographical Location"],"points":[{"start":38,"end":45,"text":"Illumina"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":36,"text":"cDNA library prepared validated using"}]}],"extras":null,"metadata":{"first_done_at":1542149281000,"last_updated_at":1542149281000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "RNA seq performed according Illumina TruSeq v3 protocol HiSeq 2500 platform resulting 100bp paired end reads","annotation":null,"extras":null,"metadata":{"first_done_at":1542155149000,"last_updated_at":1542155149000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Fresh core needle biopsies fresh tumor tissue examined pathologist","annotation":[{"label":["Cell type/tissue"],"points":[{"start":11,"end":54,"text":"resh core needle biopsies fresh tumor tissue"}]}],"extras":null,"metadata":{"first_done_at":1542158700000,"last_updated_at":1542158700000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Total RNA well DNA protein extracted applying QIAGEN All Prep Kit","annotation":[{"label":["teat"],"points":[{"start":0,"end":64,"text":"Total RNA well DNA protein extracted applying QIAGEN All Prep Kit"}]}],"extras":null,"metadata":{"first_done_at":1542143132000,"last_updated_at":1542143132000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "illumina TruSeq Stranded Total RNA Library Prep Kit used according manufacturer instructions","annotation":null,"extras":null,"metadata":{"first_done_at":1542153098000,"last_updated_at":1542153098000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "RNA extracted whole cells cellular fractions nucleoplasmic nuclear minus nucleoli","annotation":[{"label":["Treatment and conditions"],"points":[{"start":26,"end":80,"text":"cellular fractions nucleoplasmic nuclear minus nucleoli"}]},{"label":["Cell type/tissue"],"points":[{"start":14,"end":24,"text":"whole cells"}]}],"extras":null,"metadata":{"first_done_at":1542140331000,"last_updated_at":1542140331000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Libraries prepared using NEB library prep kit long RNAs","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":54,"text":"Libraries prepared using NEB library prep kit long RNAs"}]}],"extras":null,"metadata":{"first_done_at":1542150044000,"last_updated_at":1542150044000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols mCherry PLK4 transgenic mouse obtained Renata Basto Centre de Recherche","annotation":[{"label":["Geographical Location"],"points":[{"start":49,"end":80,"text":"Renata Basto Centre de Recherche"}]},{"label":["Genotype"],"points":[{"start":18,"end":38,"text":"PLK4 transgenic mouse"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":38,"text":"Protocols mCherry PLK4 transgenic mouse"}]}],"extras":null,"metadata":{"first_done_at":1542154217000,"last_updated_at":1542154217000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "K14Cre mice kind gift Elaine Fuchs 24 Howard Hughes Medical Institute","annotation":[{"label":["Geographical Location"],"points":[{"start":38,"end":68,"text":"Howard Hughes Medical Institute"}]},{"label":["Genotype"],"points":[{"start":0,"end":10,"text":"K14Cre mice"}]}],"extras":null,"metadata":{"first_done_at":1542137153000,"last_updated_at":1542137153000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "hole genome DNA libraries created using Illumina TruSeq DNA sample preparation kit V2 according manufacturer instructions","annotation":[{"label":["Geographical Location"],"points":[{"start":96,"end":107,"text":"manufacturer"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":94,"text":"hole genome DNA libraries created using Illumina TruSeq DNA sample preparation kit V2 according"}]}],"extras":null,"metadata":{"first_done_at":1542140636000,"last_updated_at":1542140636000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Hela cells 60 confluent treated siRNA non targeting D 001810 10 20","annotation":[{"label":["Treatment and conditions"],"points":[{"start":21,"end":75,"text":"60 confluent treated siRNA non targeting D 001810 10 20"}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":19,"text":"Hela cells"}]}],"extras":null,"metadata":{"first_done_at":1542152255000,"last_updated_at":1542152255000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Human melanoma cell line isolated pleural effusion 31 year old female metastatic","annotation":[{"label":["Disease state"],"points":[{"start":34,"end":49,"text":"pleural effusion"}]},{"label":["Cell type/tissue"],"points":[{"start":6,"end":18,"text":"melanoma cell"}]}],"extras":null,"metadata":{"first_done_at":1542152081000,"last_updated_at":1542152081000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Gene expression analysis cells produced microarrays MDA MB 435 clustered cell lines melanoma origin instead breast","annotation":[{"label":["Disease state"],"points":[{"start":84,"end":98,"text":"melanoma origin"}]},{"label":["Cell type/tissue"],"points":[{"start":52,"end":83,"text":"MDA MB 435 clustered cell lines "}]}],"extras":null,"metadata":{"first_done_at":1542148555000,"last_updated_at":1542148555000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "We describe targeted exon sequencing data derived case atypical promyelocytic leukemia associated STAT5B RARA fusion gene","annotation":[{"label":["Genotype"],"points":[{"start":98,"end":120,"text":"STAT5B RARA fusion gene"}]},{"label":["Disease state"],"points":[{"start":55,"end":76,"text":"atypical promyelocytic"}]}],"extras":null,"metadata":{"first_done_at":1542148680000,"last_updated_at":1542148680000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The case highlights next generation sequencing help establish diagnoses difficult cases guide selection therapy","annotation":null,"extras":null,"metadata":{"first_done_at":1542157121000,"last_updated_at":1542157121000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "37 C 5 CO2 following standard protocols Myotubes day 1 treated 100 uM H2O2 24 hours Illumina prep library","annotation":null,"extras":null,"metadata":{"first_done_at":1542156180000,"last_updated_at":1542156180000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Cells fixed using 1 formaldehyde 10 min room temperature fixation quenched 150 mM glycine","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":88,"text":"Cells fixed using 1 formaldehyde 10 min room temperature fixation quenched 150 mM glycine"}]}],"extras":null,"metadata":{"first_done_at":1542154076000,"last_updated_at":1542154076000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Neural stem cells cultured proliferation promoting medium Chromatin Immunoprecipitation antibodies Olig2 Millipore","annotation":[{"label":["Treatment and conditions"],"points":[{"start":27,"end":123,"text":" cultured proliferation promoting medium Chromatin Immunoprecipitation antibodies Olig2 Millipore"}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":26,"text":"Neural stem cells"}]}],"extras":null,"metadata":{"first_done_at":1542158751000,"last_updated_at":1542158751000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Cervical cerclage using braided suture material prevention preterm birth induces significant disruption vaginal microbial stability increases inflammation leading premature cervical remodeling adverse pregnancy outcomes","annotation":[{"label":["Disease state"],"points":[{"start":163,"end":191,"text":"premature cervical remodeling"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":218,"text":"Cervical cerclage using braided suture material prevention preterm birth induces significant disruption vaginal microbial stability increases inflammation leading premature cervical remodeling adverse pregnancy outcomes"}]}],"extras":null,"metadata":{"first_done_at":1542152338000,"last_updated_at":1542152338000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "100 U ml recombinant human leukemia inhibitory factor Millipore","annotation":null,"extras":null,"metadata":{"first_done_at":1542157830000,"last_updated_at":1542157830000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "These TH1 cells left unstimulated stimulated 1ug ml anti CD3 anti CD28 mAbs 5 hours presence 10mM 0","annotation":[{"label":["Treatment and conditions"],"points":[{"start":21,"end":98,"text":"unstimulated stimulated 1ug ml anti CD3 anti CD28 mAbs 5 hours presence 10mM 0"}]},{"label":["Cell type/tissue"],"points":[{"start":5,"end":14,"text":" TH1 cells"}]}],"extras":null,"metadata":{"first_done_at":1542149234000,"last_updated_at":1542149234000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "A group mice AL DR 12 months moved opposite diet sequenced 15 months","annotation":[{"label":["Treatment and conditions"],"points":[{"start":29,"end":48,"text":"moved opposite diet "}]}],"extras":null,"metadata":{"first_done_at":1542153151000,"last_updated_at":1542153151000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "DNA extracted whole blood quantified Qubit Life Technologies Corporation","annotation":[{"label":["Geographical Location"],"points":[{"start":37,"end":71,"text":"Qubit Life Technologies Corporation"}]},{"label":["Cell type/tissue"],"points":[{"start":13,"end":24,"text":" whole blood"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":71,"text":"DNA extracted whole blood quantified Qubit Life Technologies Corporation"}]}],"extras":null,"metadata":{"first_done_at":1542156215000,"last_updated_at":1542156215000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "single cell suspensions testis obtained two step enzymatic digestion GFP positive FACS sorted","annotation":[{"label":["Genotype"],"points":[{"start":69,"end":80,"text":"GFP positive"}]},{"label":["Treatment and conditions"],"points":[{"start":48,"end":67,"text":" enzymatic digestion"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":29,"text":"single cell suspensions testis"}]}],"extras":null,"metadata":{"first_done_at":1542157153000,"last_updated_at":1542157153000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Human embryonic kidney HEK 293 cells tetracycline inducible expression FLAG HA tagged RBM20 described previously 5","annotation":[{"label":["Genotype"],"points":[{"start":60,"end":100,"text":"inducible expression FLAG HA tagged RBM20"}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":45,"text":"Human embryonic kidney HEK 293 cells"}]}],"extras":null,"metadata":{"first_done_at":1542142571000,"last_updated_at":1542142571000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Rosa26 CreERT2 mESCs Ring1A KO cultured described previously Endoh et al","annotation":[{"label":["Genotype"],"points":[{"start":1,"end":29,"text":"osa26 CreERT2 mESCs Ring1A KO"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":71,"text":"Rosa26 CreERT2 mESCs Ring1A KO cultured described previously Endoh et al"}]}],"extras":null,"metadata":{"first_done_at":1542157193000,"last_updated_at":1542157193000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "2012 Conditional deletion Ring1B Ring1A KO cells carried addition 800 nM tamoxifen 48 h previously described Endoh et al","annotation":[{"label":["Treatment and conditions"],"points":[{"start":65,"end":86,"text":" 800 nM tamoxifen 48 h"}]},{"label":["Cell type/tissue"],"points":[{"start":40,"end":47,"text":"KO cells"}]},{"label":["Treatment and conditions"],"points":[{"start":5,"end":41,"text":"Conditional deletion Ring1B Ring1A KO"}]}],"extras":null,"metadata":{"first_done_at":1542136748000,"last_updated_at":1542136748000,"sec_taken":34,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "bone marrow humanized mouse tissue NOD SCID IL 2Rg null mice transplanted human hematopoietic stem cells infected HIV 1 human Immunnodeficiency virus type 1","annotation":[{"label":["Species"],"points":[{"start":120,"end":148,"text":"human Immunnodeficiency virus"}]},{"label":["Disease state"],"points":[{"start":105,"end":118,"text":"infected HIV 1"}]},{"label":["Cell type/tissue"],"points":[{"start":94,"end":103,"text":"stem cells"}]},{"label":["Genotype"],"points":[{"start":35,"end":59,"text":"NOD SCID IL 2Rg null mice"}]}],"extras":null,"metadata":{"first_done_at":1542153070000,"last_updated_at":1542153070000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Quantitative analysis polyA RNA Normal human brain temporal lobe","annotation":[{"label":["Cell type/tissue"],"points":[{"start":39,"end":63,"text":"human brain temporal lobe"}]}],"extras":null,"metadata":{"first_done_at":1542150652000,"last_updated_at":1542150652000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The RNA purchased Capital Biosciences pool 5 samples originating males aged 23 29yrs old","annotation":null,"extras":null,"metadata":{"first_done_at":1542157178000,"last_updated_at":1542157178000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "We designed primers several regions within mouse TCR loci sequenced pooled PCR products","annotation":[{"label":["Genotype"],"points":[{"start":49,"end":56,"text":"TCR loci"}]},{"label":["Species"],"points":[{"start":43,"end":47,"text":"mouse"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":86,"text":"We designed primers several regions within mouse TCR loci sequenced pooled PCR products"}]}],"extras":null,"metadata":{"first_done_at":1542137911000,"last_updated_at":1542137911000,"sec_taken":44,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Small RNA sequencing data bone marrow derived macrophages upon IL4 treatment wild type Stat6 knock mice","annotation":[{"label":["Genotype"],"points":[{"start":76,"end":102,"text":" wild type Stat6 knock mice"}]},{"label":["Treatment and conditions"],"points":[{"start":63,"end":75,"text":"IL4 treatment"}]},{"label":["Cell type/tissue"],"points":[{"start":26,"end":56,"text":"bone marrow derived macrophages"}]}],"extras":null,"metadata":{"first_done_at":1542157775000,"last_updated_at":1542157775000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Hi C libraries produced tethered conformation capture protocol described originally Kalhor et al","annotation":null,"extras":null,"metadata":{"first_done_at":1542155777000,"last_updated_at":1542155777000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "DNA human tooth found site pit sanctuary near Svilengrad","annotation":[{"label":["Geographical Location"],"points":[{"start":46,"end":55,"text":"Svilengrad"}]},{"label":["Cell type/tissue"],"points":[{"start":4,"end":14,"text":"human tooth"}]}],"extras":null,"metadata":{"first_done_at":1542154496000,"last_updated_at":1542154496000,"sec_taken":35,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The pits associated Thracian culture date Early Iron Age 800 500 BC based pottery found pits","annotation":null,"extras":null,"metadata":{"first_done_at":1542135422000,"last_updated_at":1542135529000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "including 16 pits containing human skele tons parts skeletons","annotation":[{"label":["Cell type/tissue"],"points":[{"start":46,"end":60,"text":"parts skeletons"}]},{"label":["Species"],"points":[{"start":29,"end":33,"text":"human"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":27,"text":"including 16 pits containing"}]}],"extras":null,"metadata":{"first_done_at":1542138133000,"last_updated_at":1542138148000,"sec_taken":11,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Cells sorted using flow cytometry based expression GFP CD4 CD8 markers Allprep Kit QIAGEN according manufacturer protocol SureSelect Automated Strand Specific RNA library Preparation according manufacturer protocol","annotation":[{"label":["Geographical Location"],"points":[{"start":203,"end":215,"text":"manufacturer "}]},{"label":["Geographical Location"],"points":[{"start":110,"end":122,"text":"manufacturer "}]},{"label":["Treatment and conditions"],"points":[{"start":110,"end":121,"text":"manufacturer"}]},{"label":["Genotype"],"points":[{"start":61,"end":71,"text":"GFP CD4 CD8"}]},{"label":["Treatment and conditions"],"points":[{"start":16,"end":79,"text":"sorted using flow cytometry based expression GFP CD4 CD8 markers"}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":14,"text":"Cells"}]}],"extras":null,"metadata":{"first_done_at":1542159598000,"last_updated_at":1542159598000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Genomic DNA extracted testis incubation sequencing library prepared genomic DNA","annotation":[{"label":["Treatment and conditions"],"points":[{"start":29,"end":78,"text":"incubation sequencing library prepared genomic DNA"}]},{"label":["Cell type/tissue"],"points":[{"start":12,"end":27,"text":"extracted testis"}]}],"extras":null,"metadata":{"first_done_at":1542150030000,"last_updated_at":1542150030000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Primary tumors NB1141 NB1142 fresh tumors samples obtained surgery placed liquid nitrogen stored frozen 80 C liquid nitrogen RNA extraction","annotation":null,"extras":null,"metadata":{"first_done_at":1542159174000,"last_updated_at":1542159174000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Sequences IGHV encoding genes amplified 5 Biomed2 primers 3 CH1 primers found cells paired samples human bone marrow peripheral blood","annotation":[{"label":["Cell type/tissue"],"points":[{"start":99,"end":132,"text":"human bone marrow peripheral blood"}]},{"label":["Treatment and conditions"],"points":[{"start":30,"end":71,"text":"amplified 5 Biomed2 primers 3 CH1 primers "}]},{"label":["Genotype"],"points":[{"start":10,"end":28,"text":"IGHV encoding genes"}]}],"extras":null,"metadata":{"first_done_at":1542142746000,"last_updated_at":1542142746000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Resting splenic B cells isolated 6 8 week old wild type C57BL6 J mice anti CD43 Microbeads anti Ly48","annotation":[{"label":["Genotype"],"points":[{"start":42,"end":68,"text":"old wild type C57BL6 J mice"}]},{"label":["Treatment and conditions"],"points":[{"start":24,"end":41,"text":"isolated 6 8 week "}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":22,"text":"Resting splenic B cells"}]}],"extras":null,"metadata":{"first_done_at":1542159433000,"last_updated_at":1542159433000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "5 g ml 1 anti CD180 RP105 antibody RP 14","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":39,"text":"5 g ml 1 anti CD180 RP105 antibody RP 14"}]}],"extras":null,"metadata":{"first_done_at":1542140177000,"last_updated_at":1542140177000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Tissue extracts 3 biological replicates strain subjected sucrose gradient fractionation","annotation":null,"extras":null,"metadata":{"first_done_at":1542157874000,"last_updated_at":1542157874000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "DNA isolated using NucleoSpin Gel PCR cleanup Kit Macherey Nagel","annotation":null,"extras":null,"metadata":{"first_done_at":1542159393000,"last_updated_at":1542159393000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Tissue precipitated centrifugation 1 min 14000 rpm snap frozen dry ice","annotation":null,"extras":null,"metadata":{"first_done_at":1542157796000,"last_updated_at":1542157796000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The aqueous portion breast milk samples enriched extracellular vesicles using ExoQuick Exosome Precipitation SolutionTM System Biosciences","annotation":[{"label":["Geographical Location"],"points":[{"start":120,"end":137,"text":"System Biosciences"}]},{"label":["Treatment and conditions"],"points":[{"start":40,"end":137,"text":"enriched extracellular vesicles using ExoQuick Exosome Precipitation SolutionTM System Biosciences"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":39,"text":"The aqueous portion breast milk samples "}]}],"extras":null,"metadata":{"first_done_at":1542154412000,"last_updated_at":1542154412000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "CA total RNA isolated using miRNeasy small RNA isolation kit Qiagen using manufacturers protocol","annotation":null,"extras":null,"metadata":{"first_done_at":1542156178000,"last_updated_at":1542156178000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Library preparation performed using ScriptMinerTM Small RNA Seq Library preparation Kit Epicentre Biotechnologies","annotation":[{"label":["Geographical Location"],"points":[{"start":88,"end":112,"text":"Epicentre Biotechnologies"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":86,"text":"Library preparation performed using ScriptMinerTM Small RNA Seq Library preparation Kit"}]}],"extras":null,"metadata":{"first_done_at":1542151280000,"last_updated_at":1542151280000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Fluorescent activated cell sorting performed dispersed human islets using cell surface antibodies 1 20 secondary antibodies 1 200","annotation":[{"label":["Cell type/tissue"],"points":[{"start":84,"end":87,"text":"cell"}]},{"label":["Cell type/tissue"],"points":[{"start":32,"end":35,"text":"cell"}]},{"label":["Treatment and conditions"],"points":[{"start":10,"end":30,"text":"Fluorescent activated"}]}],"extras":null,"metadata":{"first_done_at":1542141061000,"last_updated_at":1542141061000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Transgenic mice originally generated B6D2F1 hybrid strain C57BL 6 X DBA2 subsequently stabilized C57BL 6 background 10 successive rounds inter breeding","annotation":[{"label":["Treatment and conditions"],"points":[{"start":73,"end":95,"text":"subsequently stabilized"}]},{"label":["Genotype"],"points":[{"start":0,"end":114,"text":"Transgenic mice originally generated B6D2F1 hybrid strain C57BL 6 X DBA2 subsequently stabilized C57BL 6 background"}]}],"extras":null,"metadata":{"first_done_at":1542136218000,"last_updated_at":1542136218000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "380 ng DNA 100 microL subjected sonication following parameters power setting low","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":80,"text":"380 ng DNA 100 microL subjected sonication following parameters power setting low"}]}],"extras":null,"metadata":{"first_done_at":1542150231000,"last_updated_at":1542150231000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The sampling region described nodal region previous pregnancy placentas attached uterus","annotation":[{"label":["Treatment and conditions"],"points":[{"start":42,"end":86,"text":" previous pregnancy placentas attached uterus"}]},{"label":["Cell type/tissue"],"points":[{"start":30,"end":41,"text":"nodal region"}]}],"extras":null,"metadata":{"first_done_at":1542157734000,"last_updated_at":1542157734000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The goal study identify role Rbpj postpartum repair uterine endometrium","annotation":[{"label":["Cell type/tissue"],"points":[{"start":52,"end":70,"text":"uterine endometrium"}]},{"label":["Treatment and conditions"],"points":[{"start":29,"end":70,"text":"Rbpj postpartum repair uterine endometrium"}]},{"label":["Genotype"],"points":[{"start":29,"end":50,"text":"Rbpj postpartum repair"}]}],"extras":null,"metadata":{"first_done_at":1542158660000,"last_updated_at":1542158660000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The SW480 cell line originated surgical specimen primary tumor moderately differentiated colon adenocarcinoma grade 4","annotation":[{"label":["Disease state"],"points":[{"start":89,"end":116,"text":"colon adenocarcinoma grade 4"}]},{"label":["Treatment and conditions"],"points":[{"start":20,"end":87,"text":"originated surgical specimen primary tumor moderately differentiated"}]},{"label":["Cell type/tissue"],"points":[{"start":4,"end":18,"text":"SW480 cell line"}]}],"extras":null,"metadata":{"first_done_at":1542143292000,"last_updated_at":1542143292000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Spleens mashed 70nm strainer obtain single cell suspension Cells grown complete IMDM 10 FBS","annotation":[{"label":["Treatment and conditions"],"points":[{"start":48,"end":90,"text":"suspension Cells grown complete IMDM 10 FBS"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":46,"text":"Spleens mashed 70nm strainer obtain single cell"}]}],"extras":null,"metadata":{"first_done_at":1542151123000,"last_updated_at":1542151123000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "presence IL4 10ng ml Libraries prepared according Illumina Paired End sequencing Protocl","annotation":null,"extras":null,"metadata":{"first_done_at":1542156281000,"last_updated_at":1542156281000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Human Aortic Endothelial Cells HAoEC 35 years old Caucasian male donor cause death Motor vehicle accident MVA provided Lonza Walkersville","annotation":[{"label":["Geographical Location"],"points":[{"start":119,"end":136,"text":"Lonza Walkersville"}]},{"label":["Treatment and conditions"],"points":[{"start":71,"end":104,"text":"cause death Motor vehicle accident"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":30,"text":"Human Aortic Endothelial Cells "}]}],"extras":null,"metadata":{"first_done_at":1542141341000,"last_updated_at":1542141368000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "4 mg folic acid kg diet entire duration pregnancy","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":48,"text":"4 mg folic acid kg diet entire duration pregnancy"}]}],"extras":null,"metadata":{"first_done_at":1542155865000,"last_updated_at":1542155865000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "H3K27me3 CTCF ChIP samples along control input whole cell extract produced Mouse ES Cells V6","annotation":[{"label":["Cell type/tissue"],"points":[{"start":47,"end":88,"text":"whole cell extract produced Mouse ES Cells"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":91,"text":"H3K27me3 CTCF ChIP samples along control input whole cell extract produced Mouse ES Cells V6"}]},{"label":["Genotype"],"points":[{"start":0,"end":12,"text":"H3K27me3 CTCF"}]}],"extras":null,"metadata":{"first_done_at":1542157462000,"last_updated_at":1542157462000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Short long RNA fractions separated DNase treated cell fractionation starting 1","annotation":[{"label":["Cell type/tissue"],"points":[{"start":41,"end":52,"text":"treated cell"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":77,"text":"Short long RNA fractions separated DNase treated cell fractionation starting 1"}]}],"extras":null,"metadata":{"first_done_at":1542139518000,"last_updated_at":1542139518000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "A Human Brain Reference Total RNA HBRR sample pooled obtained brain samples 23 individuals Ambion","annotation":null,"extras":null,"metadata":{"first_done_at":1542140432000,"last_updated_at":1542140460000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The total RNAs isolated mouse cerebral cortex TRIzol Life Technologies","annotation":[{"label":["Geographical Location"],"points":[{"start":52,"end":69,"text":" Life Technologies"}]},{"label":["Cell type/tissue"],"points":[{"start":24,"end":44,"text":"mouse cerebral cortex"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":22,"text":"The total RNAs isolated"}]}],"extras":null,"metadata":{"first_done_at":1542141215000,"last_updated_at":1542141215000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Total RNA selected twice Sera Mag Magnetic Oligo dT Beads Thermo Scientific isolate poly A RNA","annotation":[{"label":["Geographical Location"],"points":[{"start":58,"end":74,"text":"Thermo Scientific"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":93,"text":"Total RNA selected twice Sera Mag Magnetic Oligo dT Beads Thermo Scientific isolate poly A RNA"}]}],"extras":null,"metadata":{"first_done_at":1542150575000,"last_updated_at":1542150575000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "human gastric organoid Protocols hGOs generated 34 day step wise directed differentiation protocol pluripotent stem cells","annotation":[{"label":["Cell type/tissue"],"points":[{"start":99,"end":120,"text":"pluripotent stem cells"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":120,"text":"human gastric organoid Protocols hGOs generated 34 day step wise directed differentiation protocol pluripotent stem cells"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":21,"text":"human gastric organoid"}]}],"extras":null,"metadata":{"first_done_at":1542138068000,"last_updated_at":1542138068000,"sec_taken":53,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "2011 A Low Cost Library Construction Protocol Data Analysis Pipeline Illumina Based Strand Specific Multiplex RNA Seq","annotation":null,"extras":null,"metadata":{"first_done_at":1542156530000,"last_updated_at":1542156530000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "2001 Fractionation Ter119 Ter119 cells Miltenyi beads Schuh et al","annotation":[{"label":["Cell type/tissue"],"points":[{"start":19,"end":37,"text":"Ter119 Ter119 cells"}]}],"extras":null,"metadata":{"first_done_at":1542152097000,"last_updated_at":1542152097000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Total mRNA extracted using TRI Reagent Sigma Aldrich according manufacturer protocol","annotation":[{"label":["Geographical Location"],"points":[{"start":63,"end":74,"text":"manufacturer"}]},{"label":["Treatment and conditions"],"points":[{"start":27,"end":51,"text":"TRI Reagent Sigma Aldrich"}]}],"extras":null,"metadata":{"first_done_at":1542149318000,"last_updated_at":1542149318000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Small non coding RNA fractions prepared cultured hippocampal neurons","annotation":[{"label":["Cell type/tissue"],"points":[{"start":49,"end":67,"text":"hippocampal neurons"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":38,"text":"Small non coding RNA fractions prepared"}]},{"label":["Genotype"],"points":[{"start":0,"end":19,"text":"Small non coding RNA"}]}],"extras":null,"metadata":{"first_done_at":1542157317000,"last_updated_at":1542157317000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "40 bp deletion occurred beginning exon 5 bp 643 bp 682","annotation":[{"label":["Genotype"],"points":[{"start":15,"end":53,"text":"occurred beginning exon 5 bp 643 bp 682"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":53,"text":"40 bp deletion occurred beginning exon 5 bp 643 bp 682"}]}],"extras":null,"metadata":{"first_done_at":1542153979000,"last_updated_at":1542154014000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "40 50ng immunoprecipitated DNA end repaired ligated adapters DNA fragments using NEBNext Ultra End Repair dA Tailing Module NEBNext Ultra Ligation Module NEB","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":156,"text":"40 50ng immunoprecipitated DNA end repaired ligated adapters DNA fragments using NEBNext Ultra End Repair dA Tailing Module NEBNext Ultra Ligation Module NEB"}]}],"extras":null,"metadata":{"first_done_at":1542138801000,"last_updated_at":1542138801000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Each sample amplified 14 cycles DNA thermal cycler using Q5 High Fidelity DNA Polymerase NEB","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":91,"text":"Each sample amplified 14 cycles DNA thermal cycler using Q5 High Fidelity DNA Polymerase NEB"}]}],"extras":null,"metadata":{"first_done_at":1542141691000,"last_updated_at":1542141691000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Cell lines grown RPMI 1640 10 fetal bovine serum 1x penicillin streptomycin Invitrogen","annotation":null,"extras":null,"metadata":{"first_done_at":1542135502000,"last_updated_at":1542135530000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Extracted RNA pooled DNase treated using DNAfree kit Ambion","annotation":null,"extras":null,"metadata":{"first_done_at":1542151740000,"last_updated_at":1542151740000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "mRNA enriched binding oligo dT beads using uMACS system Miltenyi Biotech","annotation":[{"label":["Geographical Location"],"points":[{"start":56,"end":71,"text":"Miltenyi Biotech"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":71,"text":"mRNA enriched binding oligo dT beads using uMACS system Miltenyi Biotech"}]}],"extras":null,"metadata":{"first_done_at":1542159365000,"last_updated_at":1542159365000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "First second strand cDNA synthesis carried using Superscript double stranded cDNA synthesis kit Invitrogen","annotation":null,"extras":null,"metadata":{"first_done_at":1542156990000,"last_updated_at":1542156990000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The objective project observe effect sodium fluoride DNA methylation pattern HOS cell line correlation pathogenesis skeletal fluorosis","annotation":[{"label":["Disease state"],"points":[{"start":103,"end":133,"text":"pathogenesis skeletal fluorosis"}]},{"label":["Cell type/tissue"],"points":[{"start":76,"end":90,"text":" HOS cell line "}]},{"label":["Treatment and conditions"],"points":[{"start":22,"end":75,"text":"observe effect sodium fluoride DNA methylation pattern"}]}],"extras":null,"metadata":{"first_done_at":1542141655000,"last_updated_at":1542141655000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Vaginal microbial dysbiosis increases risk preterm pre labor rupture fetal membranes","annotation":[{"label":["Cell type/tissue"],"points":[{"start":69,"end":83,"text":"fetal membranes"}]},{"label":["Treatment and conditions"],"points":[{"start":28,"end":67,"text":"increases risk preterm pre labor rupture"}]},{"label":["Disease state"],"points":[{"start":0,"end":26,"text":"Vaginal microbial dysbiosis"}]}],"extras":null,"metadata":{"first_done_at":1542155338000,"last_updated_at":1542155338000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols The protocol describing mouse strain TC1 found http dx","annotation":[{"label":["Genotype"],"points":[{"start":34,"end":49,"text":"mouse strain TC1"}]}],"extras":null,"metadata":{"first_done_at":1542151955000,"last_updated_at":1542151955000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Hepatocytes prepared direct perfusion liver buffered salt solution followed percent formaldehyde","annotation":[{"label":["Treatment and conditions"],"points":[{"start":44,"end":95,"text":"buffered salt solution followed percent formaldehyde"}]},{"label":["Cell type/tissue"],"points":[{"start":38,"end":42,"text":"liver"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":10,"text":"Hepatocytes"}]}],"extras":null,"metadata":{"first_done_at":1542138461000,"last_updated_at":1542138461000,"sec_taken":117,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Nimblegen Sequence Capture Genomic Mus musculus A J DNA","annotation":null,"extras":null,"metadata":{"first_done_at":1542156279000,"last_updated_at":1542156279000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Immunoprecipitation performed overnight 4C 3 g antibody anti FOXM1 control IgG 30 l Dynabeads per experiment","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":107,"text":"Immunoprecipitation performed overnight 4C 3 g antibody anti FOXM1 control IgG 30 l Dynabeads per experiment"}]}],"extras":null,"metadata":{"first_done_at":1542140258000,"last_updated_at":1542140258000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols blood samples healthy donors patients collected using BD Vacutainer PAXgene Blood RNA tubes","annotation":[{"label":["Geographical Location"],"points":[{"start":64,"end":65,"text":"BD"}]},{"label":["Disease state"],"points":[{"start":24,"end":46,"text":"healthy donors patients"}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":22,"text":"blood samples"}]}],"extras":null,"metadata":{"first_done_at":1542155001000,"last_updated_at":1542155001000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Libraries prepared using TruSeq Stranded RNA Sample Preparation kit Poli A selection","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":83,"text":"Libraries prepared using TruSeq Stranded RNA Sample Preparation kit Poli A selection"}]}],"extras":null,"metadata":{"first_done_at":1542149188000,"last_updated_at":1542149188000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "129P2 Lgr5tm1 cre ERT2 Cle J strain Mus musculus mice diet corn oil cellulose given injections AOM","annotation":[{"label":["Species"],"points":[{"start":36,"end":47,"text":"Mus musculus"}]},{"label":["Genotype"],"points":[{"start":6,"end":34,"text":"Lgr5tm1 cre ERT2 Cle J strain"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":97,"text":"129P2 Lgr5tm1 cre ERT2 Cle J strain Mus musculus mice diet corn oil cellulose given injections AOM"}]}],"extras":null,"metadata":{"first_done_at":1542156080000,"last_updated_at":1542156080000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "DNA affected mouse carrying spontaneous mutation arose strain carrying Deltagen KO Cnr2 gene","annotation":[{"label":["Genotype"],"points":[{"start":28,"end":91,"text":"spontaneous mutation arose strain carrying Deltagen KO Cnr2 gene"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":26,"text":"DNA affected mouse carrying"}]}],"extras":null,"metadata":{"first_done_at":1542143537000,"last_updated_at":1542143537000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Established peripheral blood 15 year old North African girl acute lymphoblastic leukemia ALL first relapse","annotation":[{"label":["Disease state"],"points":[{"start":60,"end":105,"text":"acute lymphoblastic leukemia ALL first relapse"}]},{"label":["Geographical Location"],"points":[{"start":41,"end":53,"text":"North African"}]},{"label":["Cell type/tissue"],"points":[{"start":12,"end":27,"text":"peripheral blood"}]}],"extras":null,"metadata":{"first_done_at":1542151083000,"last_updated_at":1542151083000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols B16F10 melanoma cell line purchased 2010 American Type Culture Collection product ATCC CRL 6475","annotation":[{"label":["Cell type/tissue"],"points":[{"start":17,"end":34,"text":"melanoma cell line"}]}],"extras":null,"metadata":{"first_done_at":1542149167000,"last_updated_at":1542149167000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Stages DNA normalization procedure enrichment genome flanks somatic AluYa5 retroelement insertions human frontal cortex cell nuclei","annotation":[{"label":["Cell type/tissue"],"points":[{"start":105,"end":130,"text":"frontal cortex cell nuclei"}]},{"label":["Genotype"],"points":[{"start":60,"end":98,"text":"somatic AluYa5 retroelement insertions "}]},{"label":["Treatment and conditions"],"points":[{"start":35,"end":58,"text":"enrichment genome flanks"}]}],"extras":null,"metadata":{"first_done_at":1542151724000,"last_updated_at":1542151724000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "mi44 H2e Cytoplasmic Cytoplasmic RNA fraction mouse iPS derived lymphocytes B","annotation":[{"label":["Cell type/tissue"],"points":[{"start":46,"end":76,"text":"mouse iPS derived lymphocytes B"}]},{"label":["Genotype"],"points":[{"start":0,"end":7,"text":"mi44 H2e"}]}],"extras":null,"metadata":{"first_done_at":1542159664000,"last_updated_at":1542159664000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "mi55 A2 10 Cytoplasmic Cytoplasmic RNA fraction mouse iPS derived lymphocytes B","annotation":[{"label":["Cell type/tissue"],"points":[{"start":47,"end":78,"text":" mouse iPS derived lymphocytes B"}]},{"label":["Genotype"],"points":[{"start":0,"end":37,"text":"mi55 A2 10 Cytoplasmic Cytoplasmic RNA"}]}],"extras":null,"metadata":{"first_done_at":1542138696000,"last_updated_at":1542138696000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "mi56 H1 11 Cytoplasmic Cytoplasmic RNA fraction mouse iPS derived lymphocytes B","annotation":[{"label":["Cell type/tissue"],"points":[{"start":47,"end":78,"text":" mouse iPS derived lymphocytes B"}]},{"label":["Genotype"],"points":[{"start":0,"end":7,"text":"mi56 H1 "}]}],"extras":null,"metadata":{"first_done_at":1542159520000,"last_updated_at":1542159520000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "puri ed poly A mRNA sheared prior cDNA synthesis","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":47,"text":"puri ed poly A mRNA sheared prior cDNA synthesis"}]}],"extras":null,"metadata":{"first_done_at":1542156838000,"last_updated_at":1542156838000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "50 60 mg grey matter dissected immediately added 1 ml Trizol reagent total RNA extracted according manufacturer instructions Invitrogen","annotation":[{"label":["Geographical Location"],"points":[{"start":125,"end":134,"text":"Invitrogen"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":87,"text":"50 60 mg grey matter dissected immediately added 1 ml Trizol reagent total RNA extracted"}]}],"extras":null,"metadata":{"first_done_at":1542137056000,"last_updated_at":1542137056000,"sec_taken":60,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "poly A containing mRNA purified total RNA using streptavidin coated magnetic beads Illumina","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":90,"text":"poly A containing mRNA purified total RNA using streptavidin coated magnetic beads Illumina"}]}],"extras":null,"metadata":{"first_done_at":1542148587000,"last_updated_at":1542148587000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The cells grown conditions provided ENCODE data coordination center UCSC website frozen batches 25 million","annotation":[],"extras":null,"metadata":{"first_done_at":1542158592000,"last_updated_at":1542158592000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Human primary islets 85 95 pure purchased Prodo Laboratories Inc Irvine","annotation":[{"label":["Geographical Location"],"points":[{"start":58,"end":80,"text":"Laboratories Inc Irvine"}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":29,"text":"Human primary islets"}]}],"extras":null,"metadata":{"first_done_at":1542154520000,"last_updated_at":1542154520000,"sec_taken":58,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "USA cultured 4 days Prodo Islet Media Standard PIM S recover arrival","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":67,"text":"USA cultured 4 days Prodo Islet Media Standard PIM S recover arrival"}]}],"extras":null,"metadata":{"first_done_at":1542136004000,"last_updated_at":1542136004000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "This project contains sequence well characterized haploid cell line CHM13htert derived hydatidiform mole","annotation":[{"label":["Cell type/tissue"],"points":[{"start":49,"end":103,"text":" haploid cell line CHM13htert derived hydatidiform mole"}]}],"extras":null,"metadata":{"first_done_at":1542155188000,"last_updated_at":1542155188000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "10 fetal calf serum RNA prepared cells cultured GM DM TriReagent Life Technologies according manufacturer recommendation","annotation":[{"label":["Geographical Location"],"points":[{"start":54,"end":81,"text":"TriReagent Life Technologies"}]},{"label":["Treatment and conditions"],"points":[{"start":14,"end":52,"text":"serum RNA prepared cells cultured GM DM"}]},{"label":["Cell type/tissue"],"points":[{"start":3,"end":12,"text":"fetal calf"}]}],"extras":null,"metadata":{"first_done_at":1542142202000,"last_updated_at":1542142202000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols 10 sections formalin fixed paraffin embedded tissue histological diagnosis WHO grade 2 astrocytoma","annotation":[{"label":["Disease state"],"points":[{"start":62,"end":107,"text":"histological diagnosis WHO grade 2 astrocytoma"}]},{"label":["Cell type/tissue"],"points":[{"start":46,"end":60,"text":"embedded tissue"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":107,"text":"Protocols 10 sections formalin fixed paraffin embedded tissue histological diagnosis WHO grade 2 astrocytoma"}]}],"extras":null,"metadata":{"first_done_at":1542155915000,"last_updated_at":1542155915000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "oligodendroglioma oligo astrocytoma obtained Human Biomaterials Resource Centre University Birmingham","annotation":[{"label":["Geographical Location"],"points":[{"start":45,"end":100,"text":"Human Biomaterials Resource Centre University Birmingham"}]},{"label":["Disease state"],"points":[{"start":0,"end":34,"text":"oligodendroglioma oligo astrocytoma"}]}],"extras":null,"metadata":{"first_done_at":1542155229000,"last_updated_at":1542155242000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "RNA extracted using FFPE RNA kit per manufacturer instructions","annotation":[{"label":["Geographical Location"],"points":[{"start":37,"end":48,"text":"manufacturer"}]}],"extras":null,"metadata":{"first_done_at":1542137866000,"last_updated_at":1542137866000,"sec_taken":53,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "PG0000001 human genomic DNA derived peripheral blood lymphocytes Jay Flatley","annotation":[{"label":["Cell type/tissue"],"points":[{"start":36,"end":63,"text":"peripheral blood lymphocytes"}]},{"label":["Species"],"points":[{"start":10,"end":14,"text":"human"}]}],"extras":null,"metadata":{"first_done_at":1542157688000,"last_updated_at":1542157688000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Caecal content one 18 week old mouse fed control experimental diet 8 weeks subjected oral glucose tolerance test fasting period 6 h","annotation":[{"label":["Treatment and conditions"],"points":[{"start":7,"end":130,"text":"content one 18 week old mouse fed control experimental diet 8 weeks subjected oral glucose tolerance test fasting period 6 h"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":5,"text":"Caecal"}]}],"extras":null,"metadata":{"first_done_at":1542151011000,"last_updated_at":1542151011000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "So named lncRNA LBCS low expresses bladder cancer stem cell","annotation":[{"label":["Cell type/tissue"],"points":[{"start":50,"end":58,"text":"stem cell"}]},{"label":["Disease state"],"points":[{"start":35,"end":48,"text":"bladder cancer"}]},{"label":["Genotype"],"points":[{"start":9,"end":33,"text":"lncRNA LBCS low expresses"}]}],"extras":null,"metadata":{"first_done_at":1542156484000,"last_updated_at":1542156484000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Library preparation performed using modified Strand seq protocol 2","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":75,"text":"Protocols Library preparation performed using modified Strand seq protocol 2"}]}],"extras":null,"metadata":{"first_done_at":1542151325000,"last_updated_at":1542151325000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols 1mg kg 7 consecutive days Total RNA extracted FACS isolated GFP adipocytes preadipocytes using RNeasy Micro Kit Qiagen","annotation":[{"label":["Cell type/tissue"],"points":[{"start":74,"end":97,"text":"adipocytes preadipocytes"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":35,"text":"Protocols 1mg kg 7 consecutive days "}]}],"extras":null,"metadata":{"first_done_at":1542139296000,"last_updated_at":1542139296000,"sec_taken":58,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Libraries constructed minimum 22 ng total RNA previously described Nature 504 7478","annotation":null,"extras":null,"metadata":{"first_done_at":1542156144000,"last_updated_at":1542156144000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Embryonic BAT Brown Adipose Tissue mice postnatal stage P0 Interscapular BAT 12 weeks old","annotation":[{"label":["Treatment and conditions"],"points":[{"start":45,"end":98,"text":"mice postnatal stage P0 Interscapular BAT 12 weeks old"}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":43,"text":"Embryonic BAT Brown Adipose Tissue"}]}],"extras":null,"metadata":{"first_done_at":1542138831000,"last_updated_at":1542138831000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Peripheral blood smear revealed many RBCs stomatocytes 20 30 reticulocytes count 25","annotation":[{"label":["Cell type/tissue"],"points":[{"start":61,"end":73,"text":"reticulocytes"}]},{"label":["Cell type/tissue"],"points":[{"start":42,"end":53,"text":"stomatocytes"}]},{"label":["Treatment and conditions"],"points":[{"start":23,"end":82,"text":"revealed many RBCs stomatocytes 20 30 reticulocytes count 25"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":15,"text":"Peripheral blood"}]}],"extras":null,"metadata":{"first_done_at":1542138314000,"last_updated_at":1542138314000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "8 16 hr Formaldehyde Cross linking chromatin immunoprecipitation assays experiment performed described Boyd Farnham MCB 29 8389 8299 Y","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":133,"text":"8 16 hr Formaldehyde Cross linking chromatin immunoprecipitation assays experiment performed described Boyd Farnham MCB 29 8389 8299 Y"}]}],"extras":null,"metadata":{"first_done_at":1542151196000,"last_updated_at":1542151196000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Antibody used immunoprecipitation Rabbit p53 Santa Cruz FL 393 Purified ChIP DNA used prepare Illumina multiplexed sequencing libraries","annotation":[{"label":["Treatment and conditions"],"points":[{"start":63,"end":134,"text":"Purified ChIP DNA used prepare Illumina multiplexed sequencing libraries"}]},{"label":["Geographical Location"],"points":[{"start":45,"end":54,"text":"Santa Cruz"}]}],"extras":null,"metadata":{"first_done_at":1542137554000,"last_updated_at":1542137554000,"sec_taken":127,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Adipose tissue samples 100 150 mg supraclavicular abdominal areas obtained using suction adapted BergstrAsm needle","annotation":[{"label":["Treatment and conditions"],"points":[{"start":34,"end":123,"text":"00 150 mg supraclavicular abdominal areas obtained using suction adapted BergstrAsm needle"}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":23,"text":"Adipose tissue"}]}],"extras":null,"metadata":{"first_done_at":1542141736000,"last_updated_at":1542141736000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Mol Biol 2009 A systems approach analyze transcription factors mammalian cells","annotation":[{"label":["Disease state"],"points":[{"start":63,"end":77,"text":"mammalian cells"}]},{"label":["Treatment and conditions"],"points":[{"start":40,"end":77,"text":" transcription factors mammalian cells"}]}],"extras":null,"metadata":{"first_done_at":1542156045000,"last_updated_at":1542156045000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Libraries prepared using NEBNext Ultra DNA library prep Illumina","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":63,"text":"Libraries prepared using NEBNext Ultra DNA library prep Illumina"}]}],"extras":null,"metadata":{"first_done_at":1542155802000,"last_updated_at":1542155802000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "islets enzymatically dissociated single cells stained using surface monoclonal antibodies sorted using FACS following published protocols pmid 19383399 and27399229","annotation":[{"label":["Treatment and conditions"],"points":[{"start":46,"end":162,"text":"stained using surface monoclonal antibodies sorted using FACS following published protocols pmid 19383399 and27399229"}]},{"label":["Cell type/tissue"],"points":[{"start":21,"end":44,"text":"dissociated single cells"}]}],"extras":null,"metadata":{"first_done_at":1542150487000,"last_updated_at":1542150487000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The FACS sorted beta cells collected processed total RNA isolation","annotation":[{"label":["Treatment and conditions"],"points":[{"start":47,"end":65,"text":"total RNA isolation"}]},{"label":["Cell type/tissue"],"points":[{"start":4,"end":25,"text":"FACS sorted beta cells"}]}],"extras":null,"metadata":{"first_done_at":1542141602000,"last_updated_at":1542141602000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Isolation RNA gallbladder cells beta cells using Qiagen RNeasy protocol TruSeq RNA sample library preparation v2 recommended manufacturer Illumina","annotation":[{"label":["Geographical Location"],"points":[{"start":125,"end":136,"text":"manufacturer"}]},{"label":["Cell type/tissue"],"points":[{"start":14,"end":41,"text":"gallbladder cells beta cells"}]}],"extras":null,"metadata":{"first_done_at":1542156330000,"last_updated_at":1542156330000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "293T cells infected lentiviral vector sorted individual culturing conditions","annotation":[{"label":["Treatment and conditions"],"points":[{"start":11,"end":75,"text":"infected lentiviral vector sorted individual culturing conditions"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":9,"text":"293T cells"}]}],"extras":null,"metadata":{"first_done_at":1542139323000,"last_updated_at":1542139323000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Total RNA extracted GenElute total RNA miniprep kit","annotation":null,"extras":null,"metadata":{"first_done_at":1542158594000,"last_updated_at":1542158594000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "ES cells cultured DMEM GlutaMax Life technologies containing 15 FCS LIF Libraries prepared Truseq Stranded Total RNA Ribo Zero Gold Prep kit Illumina","annotation":[{"label":["Treatment and conditions"],"points":[{"start":60,"end":148,"text":" 15 FCS LIF Libraries prepared Truseq Stranded Total RNA Ribo Zero Gold Prep kit Illumina"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":7,"text":"ES cells"}]}],"extras":null,"metadata":{"first_done_at":1542159494000,"last_updated_at":1542159494000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "ChIP seq used find binding sites transcription factor Bcl3 K562 cells described Study category entry","annotation":[{"label":["Cell type/tissue"],"points":[{"start":59,"end":68,"text":"K562 cells"}]},{"label":["Genotype"],"points":[{"start":33,"end":57,"text":"transcription factor Bcl3"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":31,"text":"ChIP seq used find binding sites"}]}],"extras":null,"metadata":{"first_done_at":1542140008000,"last_updated_at":1542140008000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "For details please contact Myers Lab HudsonAlpha Institute Biotechnology","annotation":[{"label":["Geographical Location"],"points":[{"start":27,"end":71,"text":"Myers Lab HudsonAlpha Institute Biotechnology"}]}],"extras":null,"metadata":{"first_done_at":1542137813000,"last_updated_at":1542137813000,"sec_taken":17,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "5 Theiler Stage 23 RNA extracted following manufacturers guidlines SV","annotation":[{"label":["Geographical Location"],"points":[{"start":43,"end":55,"text":"manufacturers"}]},{"label":["Disease state"],"points":[{"start":0,"end":14,"text":"5 Theiler Stage"}]}],"extras":null,"metadata":{"first_done_at":1542149336000,"last_updated_at":1542149336000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Liver tissues male obese ob ob mice C57BL 6J background 12 weeks old male wild type littermates sequencing Illumina","annotation":[{"label":["Treatment and conditions"],"points":[{"start":56,"end":114,"text":"12 weeks old male wild type littermates sequencing Illumina"}]},{"label":["Genotype"],"points":[{"start":36,"end":43,"text":"C57BL 6J"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":12,"text":"Liver tissues"}]}],"extras":null,"metadata":{"first_done_at":1542156883000,"last_updated_at":1542156883000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "rna extracted using norgen total rna kit neb next ultra rna seq kit using multiplexed indexes","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":92,"text":"rna extracted using norgen total rna kit neb next ultra rna seq kit using multiplexed indexes"}]}],"extras":null,"metadata":{"first_done_at":1542151308000,"last_updated_at":1542151308000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "DNA extracted WT ES cells first digested MspI restriction enzyme","annotation":[{"label":["Treatment and conditions"],"points":[{"start":26,"end":63,"text":"first digested MspI restriction enzyme"}]},{"label":["Cell type/tissue"],"points":[{"start":17,"end":24,"text":"ES cells"}]},{"label":["Genotype"],"points":[{"start":14,"end":18,"text":"WT ES"}]}],"extras":null,"metadata":{"first_done_at":1542150896000,"last_updated_at":1542150896000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Mouse erythroleukemia MEL cells primary erythroid progenitors obtained fetal liver E13","annotation":[{"label":["Cell type/tissue"],"points":[{"start":0,"end":85,"text":"Mouse erythroleukemia MEL cells primary erythroid progenitors obtained fetal liver E13"}]}],"extras":null,"metadata":{"first_done_at":1542150947000,"last_updated_at":1542150947000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "5 mouse embryos cultured previously described Soler et al","annotation":[{"label":["Cell type/tissue"],"points":[{"start":8,"end":23,"text":"embryos cultured"}]},{"label":["Species"],"points":[{"start":0,"end":6,"text":"5 mouse"}]}],"extras":null,"metadata":{"first_done_at":1542150803000,"last_updated_at":1542150803000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "10U ml EPO 1 mg ml Transferrin 16 hours","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":38,"text":"10U ml EPO 1 mg ml Transferrin 16 hours"}]}],"extras":null,"metadata":{"first_done_at":1542155972000,"last_updated_at":1542155972000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The diagnosis NKTCL made according 2008 World Health Organization WHO classification tumors hematopoietic lymphoid tissues","annotation":[{"label":["Cell type/tissue"],"points":[{"start":106,"end":121,"text":"lymphoid tissues"}]},{"label":["Geographical Location"],"points":[{"start":40,"end":68,"text":"World Health Organization WHO"}]},{"label":["Treatment and conditions"],"points":[{"start":20,"end":83,"text":"made according 2008 World Health Organization WHO classification"}]},{"label":["Disease state"],"points":[{"start":0,"end":18,"text":"The diagnosis NKTCL"}]}],"extras":null,"metadata":{"first_done_at":1542139579000,"last_updated_at":1542139579000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The cancer defined non CIMP tumor satisfying criteria DNA methylation CACNA1G","annotation":[{"label":["Genotype"],"points":[{"start":45,"end":76,"text":"criteria DNA methylation CACNA1G"}]},{"label":["Disease state"],"points":[{"start":0,"end":9,"text":"The cancer"}]}],"extras":null,"metadata":{"first_done_at":1542138482000,"last_updated_at":1542138482000,"sec_taken":21,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Understanding regulatory mechanisms differential gene expression vital step elucidate organismal morphogenesis","annotation":[],"extras":null,"metadata":{"first_done_at":1542156012000,"last_updated_at":1542156012000,"sec_taken":40,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The PBMC samples 2 TB patient 2 healthy control","annotation":[{"label":["Disease state"],"points":[{"start":32,"end":46,"text":"healthy control"}]},{"label":["Cell type/tissue"],"points":[{"start":4,"end":15,"text":"PBMC samples"}]}],"extras":null,"metadata":{"first_done_at":1542156981000,"last_updated_at":1542156981000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "100mg ml glycogen Invitrogen 20mg ml recombinant histone 2B M2505S","annotation":[{"label":["Genotype"],"points":[{"start":37,"end":65,"text":"recombinant histone 2B M2505S"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":35,"text":"100mg ml glycogen Invitrogen 20mg ml"}]}],"extras":null,"metadata":{"first_done_at":1542140203000,"last_updated_at":1542140203000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "New England Biolabs 1mg ml human mRNA Invitrogen added carriers ChIP","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":67,"text":"New England Biolabs 1mg ml human mRNA Invitrogen added carriers ChIP"}]},{"label":["Geographical Location"],"points":[{"start":0,"end":18,"text":"New England Biolabs"}]}],"extras":null,"metadata":{"first_done_at":1542156855000,"last_updated_at":1542156855000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols OE33 cells grown RPMI media supplemented 10 foetal bovine serum","annotation":[{"label":["Treatment and conditions"],"points":[{"start":21,"end":72,"text":"grown RPMI media supplemented 10 foetal bovine serum"}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":19,"text":"OE33 cells"}]}],"extras":null,"metadata":{"first_done_at":1542149472000,"last_updated_at":1542149472000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Cell lines cultured 37 C 5 CO2 McCoy 5A medium supplemented 10 v v foetal calf serum","annotation":[{"label":["Cell type/tissue"],"points":[{"start":77,"end":93,"text":"foetal calf serum"}]},{"label":["Treatment and conditions"],"points":[{"start":21,"end":76,"text":"cultured 37 C 5 CO2 McCoy 5A medium supplemented 10 v v "}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":19,"text":"Protocols Cell lines"}]}],"extras":null,"metadata":{"first_done_at":1542151420000,"last_updated_at":1542151420000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "100 U ml penicillin 100 microgram ml streptomycin humidified incubator 37 degrees Celcius 5 CO2","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":94,"text":"100 U ml penicillin 100 microgram ml streptomycin humidified incubator 37 degrees Celcius 5 CO2"}]}],"extras":null,"metadata":{"first_done_at":1542149207000,"last_updated_at":1542149207000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Libraries prepared using manufacturer recommendations TruSeq adapters Illumina adapters","annotation":null,"extras":null,"metadata":{"first_done_at":1542159248000,"last_updated_at":1542159248000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Total RNA extracted using QIAzol lysis reagent Qiagen according manufacturer instructions","annotation":null,"extras":null,"metadata":{"first_done_at":1542155774000,"last_updated_at":1542155774000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Human Cal51 breast carcinoma cells treated either control siRNA PRPF8 siRNA harvested 54 hours post transfection total RNA","annotation":[{"label":["Treatment and conditions"],"points":[{"start":45,"end":131,"text":"treated either control siRNA PRPF8 siRNA harvested 54 hours post transfection total RNA"}]},{"label":["Disease state"],"points":[{"start":22,"end":38,"text":"breast carcinoma "}]}],"extras":null,"metadata":{"first_done_at":1542150691000,"last_updated_at":1542150691000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Inducible RsCre Rif1 ES cells cultured two four days presence tamoxifen Primary restriction digest performed incubation HindIII","annotation":[{"label":["Treatment and conditions"],"points":[{"start":30,"end":126,"text":"cultured two four days presence tamoxifen Primary restriction digest performed incubation HindIII"}]},{"label":["Cell type/tissue"],"points":[{"start":21,"end":28,"text":"ES cells"}]},{"label":["Genotype"],"points":[{"start":10,"end":19,"text":"RsCre Rif1"}]}],"extras":null,"metadata":{"first_done_at":1542158721000,"last_updated_at":1542158721000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols CD4 CD44highCD62L cells isolated Egr2 3 DKO mice FACS GFP Egr2 knockin Egr2 Kin hCD2 Cre Egr2loxP loxP Egr3 Egr2 3 DKO mice infected intranasally 2 x 105 PFU vaccinia virus 10ul physiological saline","annotation":[{"label":["Disease state"],"points":[{"start":134,"end":181,"text":"infected intranasally 2 x 105 PFU vaccinia virus"}]},{"label":["Genotype"],"points":[{"start":81,"end":121,"text":"Egr2 Kin hCD2 Cre Egr2loxP loxP Egr3 Egr2"}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":32,"text":"CD4 CD44highCD62L cells"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":207,"text":"Protocols CD4 CD44highCD62L cells isolated Egr2 3 DKO mice FACS GFP Egr2 knockin Egr2 Kin hCD2 Cre Egr2loxP loxP Egr3 Egr2 3 DKO mice infected intranasally 2 x 105 PFU vaccinia virus 10ul physiological saline"}]}],"extras":null,"metadata":{"first_done_at":1542153975000,"last_updated_at":1542153975000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "CD4 CD8 T cells isolated 7 days infection RNA isolated purified using TRIzol reagent Life Technologies according manufacturer instructions RNA T cells processed directional mRNA Seq library construction using TruSeq Stranded mRNA Library Prep Kit Illumina according manufacturer protocol","annotation":[{"label":["Cell type/tissue"],"points":[{"start":143,"end":149,"text":"T cells"}]},{"label":["Geographical Location"],"points":[{"start":85,"end":124,"text":"Life Technologies according manufacturer"}]},{"label":["Treatment and conditions"],"points":[{"start":27,"end":40,"text":"days infection"}]},{"label":["Cell type/tissue"],"points":[{"start":8,"end":14,"text":"T cells"}]}],"extras":null,"metadata":{"first_done_at":1542150853000,"last_updated_at":1542150853000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols 27 total RNA samples extracted independently core peritumoral region 13 glioblastoma tumors 1 sample healthy white matter Each library generated using SOLiD SAGE Kit Barcoding Adaptor Module SOLiD RNA Barcoding Kit Catalog nos","annotation":null,"extras":null,"metadata":{"first_done_at":1542159634000,"last_updated_at":1542159634000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Please note library sample 30 generated paired end sequenced twice","annotation":null,"extras":null,"metadata":{"first_done_at":1542156115000,"last_updated_at":1542156115000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "hiCLIP iCLIP protocol followed isolate RNA bound 3XFLAG STAU1 protein amplify cDNA library described manuscript","annotation":[{"label":["Genotype"],"points":[{"start":48,"end":69,"text":" 3XFLAG STAU1 protein "}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":47,"text":"hiCLIP iCLIP protocol followed isolate RNA bound"}]}],"extras":null,"metadata":{"first_done_at":1542154277000,"last_updated_at":1542154277000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "one paired end mRNA library approximately 150bp insert size prepared using TruSeq RNA Sample Preparation Kit v2 Illumina","annotation":[{"label":["Geographical Location"],"points":[{"start":111,"end":119,"text":" Illumina"}]}],"extras":null,"metadata":{"first_done_at":1542137292000,"last_updated_at":1542137292000,"sec_taken":44,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The precipitated complexes used prepare SOLiD sequencing library using DNA fragment library kit","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":94,"text":"The precipitated complexes used prepare SOLiD sequencing library using DNA fragment library kit"}]}],"extras":null,"metadata":{"first_done_at":1542143701000,"last_updated_at":1542143701000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Caucasian male diagnosed ulcerative colitis primary sclerosing cholangitis one time exhibited likely cholestatic reaction sertraline another time exhibited symptoms mania","annotation":[{"label":["Treatment and conditions"],"points":[{"start":84,"end":131,"text":"exhibited likely cholestatic reaction sertraline"}]},{"label":["Disease state"],"points":[{"start":25,"end":73,"text":"ulcerative colitis primary sclerosing cholangitis"}]}],"extras":null,"metadata":{"first_done_at":1542155959000,"last_updated_at":1542155959000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "5 mouse ventral midbrain tissue laser capture tyrosine hydroxylase stained brain sections Total RNA extracted using Arcturus Pico pure RNA extraction kit according manufacturer protocol Trueseq illumina library construction protocol used according manufacturer specifications","annotation":[{"label":["Geographical Location"],"points":[{"start":247,"end":259,"text":" manufacturer"}]},{"label":["Geographical Location"],"points":[{"start":163,"end":175,"text":" manufacturer"}]},{"label":["Cell type/tissue"],"points":[{"start":75,"end":88,"text":"brain sections"}]},{"label":["Treatment and conditions"],"points":[{"start":32,"end":44,"text":"laser capture"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":30,"text":"5 mouse ventral midbrain tissue"}]}],"extras":null,"metadata":{"first_done_at":1542142018000,"last_updated_at":1542142018000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "GM12878 lymphoblastoid cell line produced blood female donor northern western European ancestry EBV transformation","annotation":[{"label":["Genotype"],"points":[{"start":96,"end":113,"text":"EBV transformation"}]},{"label":["Geographical Location"],"points":[{"start":61,"end":94,"text":"northern western European ancestry"}]},{"label":["Cell type/tissue"],"points":[{"start":8,"end":31,"text":"lymphoblastoid cell line"}]}],"extras":null,"metadata":{"first_done_at":1542154357000,"last_updated_at":1542154357000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Cells cultured DMEM supplemented 10 FBS 1 penicillin streptomycin","annotation":[{"label":["Disease state"],"points":[{"start":52,"end":74,"text":"penicillin streptomycin"}]},{"label":["Treatment and conditions"],"points":[{"start":16,"end":49,"text":"cultured DMEM supplemented 10 FBS "}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":14,"text":"Cells"}]}],"extras":null,"metadata":{"first_done_at":1542156704000,"last_updated_at":1542156704000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The RNA purchased Capital Biosciences originates males aged 26 years old","annotation":[{"label":["Geographical Location"],"points":[{"start":18,"end":36,"text":"Capital Biosciences"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":71,"text":"The RNA purchased Capital Biosciences originates males aged 26 years old"}]}],"extras":null,"metadata":{"first_done_at":1542135744000,"last_updated_at":1542135778000,"sec_taken":32,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "DNA isolation performed GATC Biotech Exome enrichment performed using Agilent SureSelect Human All Exon v5","annotation":[{"label":["Treatment and conditions"],"points":[{"start":43,"end":105,"text":"enrichment performed using Agilent SureSelect Human All Exon v5"}]},{"label":["Geographical Location"],"points":[{"start":24,"end":35,"text":"GATC Biotech"}]}],"extras":null,"metadata":{"first_done_at":1542141910000,"last_updated_at":1542141910000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "We performed RNA Seq purified hair follicle stem cells HFSCs 7 dpp CD1 mice beard area","annotation":[{"label":["Genotype"],"points":[{"start":67,"end":74,"text":"CD1 mice"}]},{"label":["Cell type/tissue"],"points":[{"start":30,"end":59,"text":"hair follicle stem cells HFSCs"}]},{"label":["Treatment and conditions"],"points":[{"start":13,"end":28,"text":"RNA Seq purified"}]}],"extras":null,"metadata":{"first_done_at":1542143739000,"last_updated_at":1542143739000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Total RNA prepared isolated adipocyte tissues using Allprep DNA RNA mini kit Qiagen","annotation":[{"label":["Cell type/tissue"],"points":[{"start":28,"end":44,"text":"adipocyte tissues"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":82,"text":"Total RNA prepared isolated adipocyte tissues using Allprep DNA RNA mini kit Qiagen"}]}],"extras":null,"metadata":{"first_done_at":1542154166000,"last_updated_at":1542154166000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Set B Illumina catalog RS 122 2002 according manufacture protocol","annotation":[{"label":["Geographical Location"],"points":[{"start":45,"end":55,"text":"manufacture"}]}],"extras":null,"metadata":{"first_done_at":1542150768000,"last_updated_at":1542150768000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "RNA isolated using TriZol purified using Norgen RNA purification Kit Illumina Truseq","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":83,"text":"RNA isolated using TriZol purified using Norgen RNA purification Kit Illumina Truseq"}]}],"extras":null,"metadata":{"first_done_at":1542137374000,"last_updated_at":1542137374000,"sec_taken":81,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Wnt Signaling Controls Specification Definitive Primitive Hematopoiesis From Human Pluripotent Stem Cells","annotation":null,"extras":null,"metadata":{"first_done_at":1542156651000,"last_updated_at":1542156651000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Cell line Prostate Carcinoma derived metastatic site Cells cultured 150mm dishes 72 hours medium supplemented hormone deprived serum addition 17b Estradiol 10 7 M 45 minutes veichle ethanol Immunoprecipitate DNA Chromatin Immunoprecipitaion assay ChIP using antibody eNOS Polyclonal Rabbit Anti eNOS NOS Type III BD Transduction Laboratories","annotation":[{"label":["Geographical Location"],"points":[{"start":313,"end":340,"text":"BD Transduction Laboratories"}]},{"label":["Treatment and conditions"],"points":[{"start":59,"end":311,"text":"cultured 150mm dishes 72 hours medium supplemented hormone deprived serum addition 17b Estradiol 10 7 M 45 minutes veichle ethanol Immunoprecipitate DNA Chromatin Immunoprecipitaion assay ChIP using antibody eNOS Polyclonal Rabbit Anti eNOS NOS Type III"}]},{"label":["Disease state"],"points":[{"start":10,"end":27,"text":"Prostate Carcinoma"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":8,"text":"Cell line"}]}],"extras":null,"metadata":{"first_done_at":1542150626000,"last_updated_at":1542150626000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Assay capture sequence rearranged genomic DNA TC Seq mouse B Cells AID knockout double strand breaks induced c myc chromosome 15 loci","annotation":[{"label":["Genotype"],"points":[{"start":111,"end":132,"text":"myc chromosome 15 loci"}]},{"label":["Treatment and conditions"],"points":[{"start":94,"end":107,"text":"breaks induced"}]},{"label":["Treatment and conditions"],"points":[{"start":67,"end":92,"text":"AID knockout double strand"}]},{"label":["Cell type/tissue"],"points":[{"start":46,"end":65,"text":"TC Seq mouse B Cells"}]}],"extras":null,"metadata":{"first_done_at":1542152039000,"last_updated_at":1542152039000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Total RNA prepared three WT four Tsk2 mice skin biopsies using Qiagen RNeasy Fibrous Tissue Mini Kit","annotation":[{"label":["Cell type/tissue"],"points":[{"start":43,"end":90,"text":"skin biopsies using Qiagen RNeasy Fibrous Tissue"}]},{"label":["Genotype"],"points":[{"start":19,"end":42,"text":"three WT four Tsk2 mice "}]}],"extras":null,"metadata":{"first_done_at":1542139943000,"last_updated_at":1542139943000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "000 cm2 laminin coated vessels 10 ug ml laminin 1 Sigma PBS 6 12 h","annotation":[{"label":["Treatment and conditions"],"points":[{"start":8,"end":65,"text":"laminin coated vessels 10 ug ml laminin 1 Sigma PBS 6 12 h"}]}],"extras":null,"metadata":{"first_done_at":1542151754000,"last_updated_at":1542151754000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "passaged confluence using Accutase dissociation reagent Sigma typically split 1 3 NS cells 1 3 1 6 GNS cells","annotation":[{"label":["Cell type/tissue"],"points":[{"start":81,"end":107,"text":" NS cells 1 3 1 6 GNS cells"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":80,"text":"passaged confluence using Accutase dissociation reagent Sigma typically split 1 3"}]}],"extras":null,"metadata":{"first_done_at":1542149727000,"last_updated_at":1542149727000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "C57BL 6 specific pathogen free mice purchased Taconic farms The Jackson Laboratory","annotation":[{"label":["Treatment and conditions"],"points":[{"start":46,"end":81,"text":"Taconic farms The Jackson Laboratory"}]},{"label":["Genotype"],"points":[{"start":0,"end":15,"text":"C57BL 6 specific"}]}],"extras":null,"metadata":{"first_done_at":1542149424000,"last_updated_at":1542149424000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Female 3 week old C57BL 6 mice provided ampicillin 1 g l","annotation":[{"label":["Genotype"],"points":[{"start":18,"end":29,"text":"C57BL 6 mice"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":55,"text":"Female 3 week old C57BL 6 mice provided ampicillin 1 g l"}]}],"extras":null,"metadata":{"first_done_at":1542151822000,"last_updated_at":1542151822000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "metronidazole 1 g l drinking water 4 8 weeks previously described","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":64,"text":"metronidazole 1 g l drinking water 4 8 weeks previously described"}]}],"extras":null,"metadata":{"first_done_at":1542150036000,"last_updated_at":1542150036000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Total RNA extracted using TRIzol LS reagent according manufacturers instructions Life Technologies","annotation":null,"extras":null,"metadata":{"first_done_at":1542156237000,"last_updated_at":1542156237000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "These cells human mammary epithelial cell line derived reduction mammoplasty described Stampfer et","annotation":[{"label":["Cell type/tissue"],"points":[{"start":12,"end":46,"text":"human mammary epithelial cell line "}]}],"extras":null,"metadata":{"first_done_at":1542152826000,"last_updated_at":1542152826000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Capped transcripts enriched immunoprecipitation poly A selected Oligo dT","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":71,"text":"Capped transcripts enriched immunoprecipitation poly A selected Oligo dT"}]}],"extras":null,"metadata":{"first_done_at":1542139358000,"last_updated_at":1542139358000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols DNA extracted frozen tumor using standard methods Whole exome enrichment performed according Agilent Sureselect Human All Exon Kit protocol","annotation":null,"extras":null,"metadata":{"first_done_at":1542157667000,"last_updated_at":1542157667000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols A custom SureSelect target enrichment library design ID 0488011 designed using SureDesign online tool Agilent Technologies","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":54,"text":"Protocols A custom SureSelect target enrichment library"}]}],"extras":null,"metadata":{"first_done_at":1542136916000,"last_updated_at":1542136916000,"sec_taken":24,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Purified DMs ovarian cancer cell line UACC 1598 optimized two dimensional pulsed field gel electrophoresis collected submitted sequencin","annotation":[{"label":["Treatment and conditions"],"points":[{"start":62,"end":105,"text":"dimensional pulsed field gel electrophoresis"}]},{"label":["Disease state"],"points":[{"start":12,"end":27,"text":" ovarian cancer "}]}],"extras":null,"metadata":{"first_done_at":1542137113000,"last_updated_at":1542137113000,"sec_taken":57,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "38 weeks female Sample 1 23 24 weeks male Sample 2 purchased Capital Biosciences","annotation":[{"label":["Geographical Location"],"points":[{"start":61,"end":79,"text":"Capital Biosciences"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":49,"text":"38 weeks female Sample 1 23 24 weeks male Sample 2"}]}],"extras":null,"metadata":{"first_done_at":1542149665000,"last_updated_at":1542149665000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The commercial adult frontal lobe polyA RNA sample two rounds polyA selection acquired Clontech Catalogue number 636165","annotation":null,"extras":null,"metadata":{"first_done_at":1542158448000,"last_updated_at":1542158448000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The SOLiD RNA seq protocol used prepare RNA libraries","annotation":null,"extras":null,"metadata":{"first_done_at":1542151966000,"last_updated_at":1542151966000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "HeLaS3 cells transfected 10nMol l siRNA using Interferin reagent Polyplus according manufacturer instructions","annotation":[{"label":["Geographical Location"],"points":[{"start":84,"end":96,"text":"manufacturer "}]},{"label":["Genotype"],"points":[{"start":25,"end":56,"text":"10nMol l siRNA using Interferin "}]},{"label":["Treatment and conditions"],"points":[{"start":13,"end":63,"text":"transfected 10nMol l siRNA using Interferin reagent"}]},{"label":["cells"],"points":[{"start":0,"end":11,"text":"HeLaS3 cells"}]}],"extras":null,"metadata":{"first_done_at":1542141561000,"last_updated_at":1542141561000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Total RNA extracted using Tri reagent according manufacturers protocol Sigma","annotation":null,"extras":null,"metadata":{"first_done_at":1542156559000,"last_updated_at":1542156559000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "HD701 Quantitative Multiplex DNA Reference Standard QMRS highly characterized","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":76,"text":"HD701 Quantitative Multiplex DNA Reference Standard QMRS highly characterized"}]}],"extras":null,"metadata":{"first_done_at":1542148739000,"last_updated_at":1542148739000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "A total 7 x 105 human alveolar epithelial cells A549 incubated 24 h 6 cm plates","annotation":[{"label":["Treatment and conditions"],"points":[{"start":53,"end":78,"text":"incubated 24 h 6 cm plates"}]},{"label":["Cell type/tissue"],"points":[{"start":22,"end":47,"text":"alveolar epithelial cells "}]}],"extras":null,"metadata":{"first_done_at":1542151482000,"last_updated_at":1542151482000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "human recombinant TGF b1 added final concentration 5 ng mL","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":57,"text":"human recombinant TGF b1 added final concentration 5 ng mL"}]},{"label":["Species"],"points":[{"start":0,"end":4,"text":"human"}]}],"extras":null,"metadata":{"first_done_at":1542155769000,"last_updated_at":1542155769000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "This cell line inv 3 q21q26 leads overexpression proto oncogene EVI1","annotation":[{"label":["Genotype"],"points":[{"start":15,"end":67,"text":"inv 3 q21q26 leads overexpression proto oncogene EVI1"}]},{"label":["Cell type/tissue"],"points":[{"start":4,"end":13,"text":" cell line"}]}],"extras":null,"metadata":{"first_done_at":1542141484000,"last_updated_at":1542141497000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "MOLM 1 cells cultured using medium conditions 90 RPMI 10 FBS","annotation":[{"label":["Treatment and conditions"],"points":[{"start":13,"end":59,"text":"cultured using medium conditions 90 RPMI 10 FBS"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":12,"text":"MOLM 1 cells "}]}],"extras":null,"metadata":{"first_done_at":1542155833000,"last_updated_at":1542155833000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "followed anti ER antibody sc 543 Santa Cruz Biotechnologies","annotation":[{"label":["Geographical Location"],"points":[{"start":33,"end":58,"text":"Santa Cruz Biotechnologies"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":31,"text":"followed anti ER antibody sc 543"}]}],"extras":null,"metadata":{"first_done_at":1542150402000,"last_updated_at":1542150402000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Following iCLIP protocol retrieval protein bound RNAs construction Illumina compatible libraries done described Huppertz et al","annotation":null,"extras":null,"metadata":{"first_done_at":1542156054000,"last_updated_at":1542156054000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Animals used study mixed C57BL 6 genetic backgrounds","annotation":[{"label":["Genotype"],"points":[{"start":29,"end":61,"text":"mixed C57BL 6 genetic backgrounds"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":61,"text":"Protocols Animals used study mixed C57BL 6 genetic backgrounds"}]}],"extras":null,"metadata":{"first_done_at":1542149886000,"last_updated_at":1542149886000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "5 months age looking signs dyspnoea consequence thymic hypertrophy Libraries constructed using Agilent mouse exome v1 kit","annotation":[{"label":["Cell type/tissue"],"points":[{"start":48,"end":54,"text":"thymic "}]},{"label":["Disease state"],"points":[{"start":27,"end":65,"text":"dyspnoea consequence thymic hypertrophy"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":11,"text":"5 months age"}]}],"extras":null,"metadata":{"first_done_at":1542152999000,"last_updated_at":1542152999000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Immortalized human embryonic kidney cell line HEK293T cells cultured Dulbecco modified Eagle medium supplemented 10 fetal bovine serum 1 penicillin streptomycin","annotation":[{"label":["Disease state"],"points":[{"start":145,"end":156,"text":"1 penicillin"}]},{"label":["Treatment and conditions"],"points":[{"start":70,"end":108,"text":"cultured Dulbecco modified Eagle medium"}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":68,"text":"Immortalized human embryonic kidney cell line HEK293T cells"}]}],"extras":null,"metadata":{"first_done_at":1542139403000,"last_updated_at":1542139403000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Total RNA including small RNA fraction extracted using mirVana miRNA isolation kit Ambion following manufacturer total RNA isolation procedure","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":141,"text":"Total RNA including small RNA fraction extracted using mirVana miRNA isolation kit Ambion following manufacturer total RNA isolation procedure"}]}],"extras":null,"metadata":{"first_done_at":1542150447000,"last_updated_at":1542150447000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "small RNAs size selected ligated sequencing following TruSeq Small Prep Kit Preparation Illumina","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":95,"text":"small RNAs size selected ligated sequencing following TruSeq Small Prep Kit Preparation Illumina"}]}],"extras":null,"metadata":{"first_done_at":1542150128000,"last_updated_at":1542150128000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols The analysis performed total RNA two clones HepG2WT T1","annotation":[{"label":["Genotype"],"points":[{"start":54,"end":63,"text":"HepG2WT T1"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":63,"text":"Protocols The analysis performed total RNA two clones HepG2WT T1"}]}],"extras":null,"metadata":{"first_done_at":1542154096000,"last_updated_at":1542154096000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Nuclear mitochondrial genome sequence Oase1 sample found Pe tera cu Oase","annotation":null,"extras":null,"metadata":{"first_done_at":1542159144000,"last_updated_at":1542159144000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "G1DB004008 one ENU induced mutant mice RIKEN ENU mutant mouse library","annotation":[{"label":["Genotype"],"points":[{"start":27,"end":38,"text":"mutant mice "}]},{"label":["Treatment and conditions"],"points":[{"start":15,"end":25,"text":"ENU induced"}]}],"extras":null,"metadata":{"first_done_at":1542136714000,"last_updated_at":1542136714000,"sec_taken":33,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols SAOS cells cultured Dulbecco modified Eagle medium Life Technologies supplemented 10 fetal bovine serum PAA penicillin streptomycin Life Technologies using standard conditions procedures","annotation":[{"label":["Geographical Location"],"points":[{"start":142,"end":159,"text":"Life Technologies "}]},{"label":["Disease state"],"points":[{"start":128,"end":140,"text":" streptomycin"}]},{"label":["Treatment and conditions"],"points":[{"start":92,"end":112,"text":"10 fetal bovine serum"}]},{"label":["Geographical Location"],"points":[{"start":61,"end":78,"text":"Life Technologies "}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":19,"text":"SAOS cells"}]}],"extras":null,"metadata":{"first_done_at":1542153209000,"last_updated_at":1542153209000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "DNA pelleted cell sample genotyped using Promega GenePrint 10 System","annotation":[{"label":["Cell type/tissue"],"points":[{"start":12,"end":23,"text":" cell sample"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":11,"text":"DNA pelleted"}]}],"extras":null,"metadata":{"first_done_at":1542139601000,"last_updated_at":1542139601000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "detected following irregularities D13S317 Heterozygous Imbalance 14 11 0","annotation":[{"label":["Genotype"],"points":[{"start":34,"end":63,"text":"D13S317 Heterozygous Imbalance"}]}],"extras":null,"metadata":{"first_done_at":1542141856000,"last_updated_at":1542141856000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "TAMs purified CD14 MACS lysed Peqgold TRIzol like solution based phenol chloroform","annotation":[{"label":["Treatment and conditions"],"points":[{"start":24,"end":81,"text":"lysed Peqgold TRIzol like solution based phenol chloroform"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":22,"text":"TAMs purified CD14 MACS"}]}],"extras":null,"metadata":{"first_done_at":1542157543000,"last_updated_at":1542157543000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "fixed quantities RNA taken six samples combined single sample","annotation":null,"extras":null,"metadata":{"first_done_at":1542156488000,"last_updated_at":1542156488000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "5 CO2 HGPS fibroblasts treated DMSO vehicle control MG132 6 hours rneasy mini kit TruSeq Stranded mRNA","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":101,"text":"5 CO2 HGPS fibroblasts treated DMSO vehicle control MG132 6 hours rneasy mini kit TruSeq Stranded mRNA"}]}],"extras":null,"metadata":{"first_done_at":1542143330000,"last_updated_at":1542143330000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "HCC1954 cell lines obtained ATCC R maintained RPMI medium containing 10 fetal bovine serum FBS non essential amino acids","annotation":[{"label":["Treatment and conditions"],"points":[{"start":19,"end":119,"text":"obtained ATCC R maintained RPMI medium containing 10 fetal bovine serum FBS non essential amino acids"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":17,"text":"HCC1954 cell lines"}]}],"extras":null,"metadata":{"first_done_at":1542157629000,"last_updated_at":1542157629000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "enriched streptavidin pulldown biotinylated primer extension product using primer KvDMR 4C ext described Schoenfelder et al","annotation":[{"label":["Genotype"],"points":[{"start":82,"end":89,"text":"KvDMR 4C"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":122,"text":"enriched streptavidin pulldown biotinylated primer extension product using primer KvDMR 4C ext described Schoenfelder et al"}]}],"extras":null,"metadata":{"first_done_at":1542149815000,"last_updated_at":1542149815000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The 4 cutter Csp6I used cut within prey region create uniform ends adapter ligation","annotation":[{"label":["Genotype"],"points":[{"start":4,"end":45,"text":"4 cutter Csp6I used cut within prey region"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":82,"text":"The 4 cutter Csp6I used cut within prey region create uniform ends adapter ligation"}]}],"extras":null,"metadata":{"first_done_at":1542157868000,"last_updated_at":1542157868000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Mice infected 2x10 6 plaque forming units lymphocytic choriomeningitis virus LCMV strain 13 intravenously","annotation":[{"label":["Genotype"],"points":[{"start":87,"end":100,"text":"LCMV strain 13"}]},{"label":["Disease state"],"points":[{"start":52,"end":79,"text":"lymphocytic choriomeningitis"}]}],"extras":null,"metadata":{"first_done_at":1542157972000,"last_updated_at":1542157972000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "mRNA isolated GC B cells pooled Il10f f mice 15 days infection 2 105 plaque forming units LCMV Armstrong via intraperitoneal administration rep3","annotation":[{"label":["Treatment and conditions"],"points":[{"start":109,"end":143,"text":"intraperitoneal administration rep3"}]},{"label":["Genotype"],"points":[{"start":32,"end":43,"text":"Il10f f mice"}]},{"label":["Cell type/tissue"],"points":[{"start":17,"end":24,"text":"B cells "}]}],"extras":null,"metadata":{"first_done_at":1542152370000,"last_updated_at":1542152370000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The three target sites highly similar target sites amplified sequenced Hek293 cells treated mock transfection GFP expression plasmid Cas9 sgRNA expression plasmids purified Cas9 protein sgRNA complxed liposomes","annotation":[{"label":["Genotype"],"points":[{"start":110,"end":154,"text":"GFP expression plasmid Cas9 sgRNA expression "}]},{"label":["Treatment and conditions"],"points":[{"start":84,"end":108,"text":"treated mock transfection"}]},{"label":["Cell type/tissue"],"points":[{"start":71,"end":82,"text":"Hek293 cells"}]}],"extras":null,"metadata":{"first_done_at":1542150008000,"last_updated_at":1542150008000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Hong Kong using SureSelectXT Human All Exon target enrichment kit Agilent Technologies Inc","annotation":[{"label":["Geographical Location"],"points":[{"start":0,"end":8,"text":"Hong Kong"}]}],"extras":null,"metadata":{"first_done_at":1542137232000,"last_updated_at":1542137232000,"sec_taken":46,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols RNA harvested H1299 cells stably transfected empty vector Vector p53 mutant R273H","annotation":[{"label":["Genotype"],"points":[{"start":75,"end":90,"text":"p53 mutant R273H"}]},{"label":["Cell type/tissue"],"points":[{"start":24,"end":35,"text":"H1299 cells "}]},{"label":["Treatment and conditions"],"points":[{"start":23,"end":90,"text":" H1299 cells stably transfected empty vector Vector p53 mutant R273H"}]}],"extras":null,"metadata":{"first_done_at":1542156933000,"last_updated_at":1542156933000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "lungs mice 4 6 weeks injection 4T1 0 cells","annotation":[{"label":["Cell type/tissue"],"points":[{"start":31,"end":41,"text":"4T1 0 cells"}]},{"label":["Treatment and conditions"],"points":[{"start":6,"end":29,"text":"mice 4 6 weeks injection"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":4,"text":"lungs"}]}],"extras":null,"metadata":{"first_done_at":1542149611000,"last_updated_at":1542149611000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols CD1 mice time mated obtain branchial arches OFT","annotation":[{"label":["Cell type/tissue"],"points":[{"start":37,"end":52,"text":"branchial arches"}]},{"label":["Genotype"],"points":[{"start":10,"end":12,"text":"CD1"}]}],"extras":null,"metadata":{"first_done_at":1542136252000,"last_updated_at":1542136252000,"sec_taken":34,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Library preparation samples performed using Illumina TruSeq Stranded mRNA Sample Preparation Kits Illumina","annotation":null,"extras":null,"metadata":{"first_done_at":1542157127000,"last_updated_at":1542157127000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Ascites collected 30 patients high grade serous ovarian carcinoma undergoing primary surgery University Hospital Marburg","annotation":[{"label":["Geographical Location"],"points":[{"start":103,"end":129,"text":"University Hospital Marburg"}]},{"label":["Treatment and conditions"],"points":[{"start":76,"end":101,"text":"undergoing primary surgery"}]},{"label":["Disease state"],"points":[{"start":44,"end":74,"text":" grade serous ovarian carcinoma"}]},{"label":["Cell type/tissue"],"points":[{"start":9,"end":16,"text":" Ascites"}]}],"extras":null,"metadata":{"first_done_at":1542150095000,"last_updated_at":1542150095000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "MO467 cells grown RPMI 1640 supplemented 10 FBS R152 RPMI 1640 supplemented 10 FBS 10 ng ml murine IL7 SPRIworks Beckman Coulter","annotation":[{"label":["Geographical Location"],"points":[{"start":112,"end":127,"text":" Beckman Coulter"}]},{"label":["Treatment and conditions"],"points":[{"start":12,"end":111,"text":"grown RPMI 1640 supplemented 10 FBS R152 RPMI 1640 supplemented 10 FBS 10 ng ml murine IL7 SPRIworks"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":10,"text":"MO467 cells"}]}],"extras":null,"metadata":{"first_done_at":1542151528000,"last_updated_at":1542151528000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "EBV transformed cell lines GM12716 CEPH Utah pedigree 1358","annotation":[{"label":["Species"],"points":[{"start":40,"end":57,"text":"Utah pedigree 1358"}]},{"label":["Cell type/tissue"],"points":[{"start":16,"end":25,"text":"cell lines"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":14,"text":"EBV transformed"}]}],"extras":null,"metadata":{"first_done_at":1542150747000,"last_updated_at":1542150747000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols 3D vitro models patient derived colon cancer tumors processed single cells","annotation":[{"label":["Disease state"],"points":[{"start":48,"end":60,"text":"cancer tumors"}]},{"label":["Cell type/tissue"],"points":[{"start":42,"end":83,"text":"colon cancer tumors processed single cells"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":40,"text":"Protocols 3D vitro models patient derived"}]}],"extras":null,"metadata":{"first_done_at":1542152234000,"last_updated_at":1542152234000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "testing asymmetric cycling conditions R1 500 cycles R2 100 cycles","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":64,"text":"testing asymmetric cycling conditions R1 500 cycles R2 100 cycles"}]}],"extras":null,"metadata":{"first_done_at":1542155607000,"last_updated_at":1542155607000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "read quality R1 extends CDR3 VH deteriorated Q30 300 bp","annotation":null,"extras":null,"metadata":{"first_done_at":1542156166000,"last_updated_at":1542156166000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Additional data symmetric cycling conditions made available samples D168","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":71,"text":"Additional data symmetric cycling conditions made available samples D168"}]}],"extras":null,"metadata":{"first_done_at":1542148878000,"last_updated_at":1542148878000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Total RNA extracted viable lymphoblastoid cell line anonymous male Han Chinese using Trizol Invitrogen","annotation":[{"label":["Treatment and conditions"],"points":[{"start":79,"end":101,"text":"using Trizol Invitrogen"}]},{"label":["Species"],"points":[{"start":66,"end":78,"text":" Han Chinese "}]},{"label":["Cell type/tissue"],"points":[{"start":27,"end":50,"text":"lymphoblastoid cell line"}]}],"extras":null,"metadata":{"first_done_at":1542137415000,"last_updated_at":1542137427000,"sec_taken":10,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "double stranded cDNA synthesized RNA samples using random hexamer primer reverse transcriptase Invitrogen","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":104,"text":"double stranded cDNA synthesized RNA samples using random hexamer primer reverse transcriptase Invitrogen"}]}],"extras":null,"metadata":{"first_done_at":1542139197000,"last_updated_at":1542139197000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "DNA isolated individual glands incubation 15 l Tris EDTA solution Proteinase K solution 4 h 56 C","annotation":[{"label":["Cell type/tissue"],"points":[{"start":13,"end":29,"text":"individual glands"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":95,"text":"DNA isolated individual glands incubation 15 l Tris EDTA solution Proteinase K solution 4 h 56 C"}]}],"extras":null,"metadata":{"first_done_at":1542152920000,"last_updated_at":1542152920000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Neural stem cells cultured either proliferation promoting medium proNSC quiescence promoting medium quiNSC Chromatin Immunoprecipitation antibodies H3K27ac Abcam","annotation":[{"label":["Cell type/tissue"],"points":[{"start":10,"end":26,"text":"Neural stem cells"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":170,"text":"Protocols Neural stem cells cultured either proliferation promoting medium proNSC quiescence promoting medium quiNSC Chromatin Immunoprecipitation antibodies H3K27ac Abcam"}]}],"extras":null,"metadata":{"first_done_at":1542156422000,"last_updated_at":1542156422000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols HeLa cells obtained ECACC grown SILAC labelled DMEM 10 v v SILAC dialysed Foetal Calf Serum Dundee Cell Products least 5 population doublings","annotation":[{"label":["Treatment and conditions"],"points":[{"start":30,"end":150,"text":"ECACC grown SILAC labelled DMEM 10 v v SILAC dialysed Foetal Calf Serum Dundee Cell Products least 5 population doublings"}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":20,"text":"HeLa cells "}]}],"extras":null,"metadata":{"first_done_at":1542138650000,"last_updated_at":1542138650000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Each group contain duplicated control samples hDBR1 overexpressed samples 2 EV controls Calu6","annotation":[{"label":["Treatment and conditions"],"points":[{"start":84,"end":96,"text":"2 EV controls"}]},{"label":["Genotype"],"points":[{"start":56,"end":74,"text":"hDBR1 overexpressed"}]}],"extras":null,"metadata":{"first_done_at":1542142499000,"last_updated_at":1542142499000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "RNA samples extracted cells Qiagen RNeasy Plus Mini Kit","annotation":null,"extras":null,"metadata":{"first_done_at":1542155145000,"last_updated_at":1542155145000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "DNA extracted GMP cells WT mice first digestedwith MspI restriction enzyme","annotation":[{"label":["Treatment and conditions"],"points":[{"start":51,"end":73,"text":"MspI restriction enzyme"}]},{"label":["Genotype"],"points":[{"start":24,"end":31,"text":"WT mice "}]},{"label":["Cell type/tissue"],"points":[{"start":14,"end":22,"text":"GMP cells"}]}],"extras":null,"metadata":{"first_done_at":1542153280000,"last_updated_at":1542153280000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "expression AAV stuffer treated animals compared mice treated PBS","annotation":null,"extras":null,"metadata":{"first_done_at":1542157891000,"last_updated_at":1542157891000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The library prepared using ScriptSeq kit version 1 Epicentre","annotation":null,"extras":null,"metadata":{"first_done_at":1542156503000,"last_updated_at":1542156503000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Pol2 antybody polyclonal rabbit antibody N 20 Santa Cruz sc 899 CTCF antibody rabbit anti CTCF antiserum Millipore 07 729","annotation":[{"label":["Genotype"],"points":[{"start":57,"end":67,"text":"sc 899 CTCF"}]},{"label":["Geographical Location"],"points":[{"start":45,"end":55,"text":" Santa Cruz"}]},{"label":["Treatment and conditions"],"points":[{"start":25,"end":120,"text":"rabbit antibody N 20 Santa Cruz sc 899 CTCF antibody rabbit anti CTCF antiserum Millipore 07 729"}]}],"extras":null,"metadata":{"first_done_at":1542153324000,"last_updated_at":1542153324000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Male C57BL 6J mice 10 weeks old Jackson Laboratories entrained 12 12 LD cycle 14 days subsequently released constant darkness","annotation":[{"label":["Treatment and conditions"],"points":[{"start":66,"end":124,"text":"12 LD cycle 14 days subsequently released constant darkness"}]},{"label":["Geographical Location"],"points":[{"start":32,"end":51,"text":"Jackson Laboratories"}]},{"label":["Genotype"],"points":[{"start":5,"end":17,"text":"C57BL 6J mice"}]}],"extras":null,"metadata":{"first_done_at":1542136864000,"last_updated_at":1542136864000,"sec_taken":65,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "treated RNase A NEB purified using DNeasy Blood Tissue Kit Qiagen","annotation":[{"label":["Cell type/tissue"],"points":[{"start":41,"end":54,"text":" Blood Tissue "}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":64,"text":"treated RNase A NEB purified using DNeasy Blood Tissue Kit Qiagen"}]}],"extras":null,"metadata":{"first_done_at":1542154128000,"last_updated_at":1542154128000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "WES sequencing sample POF daughter Turkey family 2 POF daughters 4 normal daughters","annotation":[{"label":["Genotype"],"points":[{"start":51,"end":53,"text":"POF"}]},{"label":["Geographical Location"],"points":[{"start":35,"end":40,"text":"Turkey"}]},{"label":["Genotype"],"points":[{"start":22,"end":24,"text":"POF"}]}],"extras":null,"metadata":{"first_done_at":1542156397000,"last_updated_at":1542156397000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Cell cycle dependent regulation Forkhead transcription factor FOXK2 CDK cyclin complexes","annotation":[{"label":["Genotype"],"points":[{"start":32,"end":87,"text":"Forkhead transcription factor FOXK2 CDK cyclin complexes"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":30,"text":"Cell cycle dependent regulation"}]}],"extras":null,"metadata":{"first_done_at":1542138920000,"last_updated_at":1542138920000,"sec_taken":88,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Epididymal fat pad isolated treated collagenase obtain purified mature adipocytes DNA extracted using DNeasy Blood Tissue Kit Qiagen","annotation":[{"label":["Cell type/tissue"],"points":[{"start":55,"end":80,"text":"purified mature adipocytes"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":131,"text":"Epididymal fat pad isolated treated collagenase obtain purified mature adipocytes DNA extracted using DNeasy Blood Tissue Kit Qiagen"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":17,"text":"Epididymal fat pad"}]}],"extras":null,"metadata":{"first_done_at":1542157025000,"last_updated_at":1542157025000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Mice fed either 16 calorie soybean oil diet LF 44 calorie soybean oil diet HF weaning","annotation":null,"extras":null,"metadata":{"first_done_at":1542155875000,"last_updated_at":1542155875000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "characteristics E14 ES cells characteristics Chromatin immunoprecipitation CTCF transcription factor growth protocol E14 mouse ES cells","annotation":[{"label":["Treatment and conditions"],"points":[{"start":101,"end":134,"text":"growth protocol E14 mouse ES cells"}]},{"label":["Genotype"],"points":[{"start":75,"end":99,"text":"CTCF transcription factor"}]},{"label":["Cell type/tissue"],"points":[{"start":16,"end":27,"text":"E14 ES cells"}]}],"extras":null,"metadata":{"first_done_at":1542155484000,"last_updated_at":1542155484000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "ACP02 cells obtained primary gastric adenocarcinoma tissues diffuse type","annotation":[{"label":["Disease state"],"points":[{"start":29,"end":50,"text":"gastric adenocarcinoma"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":10,"text":"ACP02 cells"}]}],"extras":null,"metadata":{"first_done_at":1542154310000,"last_updated_at":1542154310000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Replicate 2 Protocols iCLIP protocol followed isolate RNA bound CPSF 160 protein amplify cDNA library described manuscript","annotation":[{"label":["Treatment and conditions"],"points":[{"start":46,"end":100,"text":"isolate RNA bound CPSF 160 protein amplify cDNA library"}]},{"label":["Cell type/tissue"],"points":[{"start":12,"end":35,"text":"Protocols iCLIP protocol"}]}],"extras":null,"metadata":{"first_done_at":1542141121000,"last_updated_at":1542141121000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Random barcodes also incoperated cDNAs distinguish PCR duplication cDNA products","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":79,"text":"Random barcodes also incoperated cDNAs distinguish PCR duplication cDNA products"}]}],"extras":null,"metadata":{"first_done_at":1542140650000,"last_updated_at":1542140650000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Human donor islets treated 8 mM glucose together Wnt3a","annotation":[{"label":["Treatment and conditions"],"points":[{"start":19,"end":53,"text":"treated 8 mM glucose together Wnt3a"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":17,"text":"Human donor islets"}]}],"extras":null,"metadata":{"first_done_at":1542149147000,"last_updated_at":1542149147000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Genomic DNA removed RNA samples using TURBO DNA freeTM Kit AM1907","annotation":null,"extras":null,"metadata":{"first_done_at":1542159631000,"last_updated_at":1542159631000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "using library preparation procedures bioinformatics pipelines designed detect circRNAs","annotation":null,"extras":null,"metadata":{"first_done_at":1542151731000,"last_updated_at":1542151731000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "followed immunoprecipitation IP Ago2 antibody isolation IP associated RNAs sequencing","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":84,"text":"followed immunoprecipitation IP Ago2 antibody isolation IP associated RNAs sequencing"}]}],"extras":null,"metadata":{"first_done_at":1542154294000,"last_updated_at":1542154294000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The result analysis reveals epigenetic alterations Parkinson disease associated genes","annotation":[{"label":["Disease state"],"points":[{"start":51,"end":67,"text":"Parkinson disease"}]},{"label":["Genotype"],"points":[{"start":28,"end":49,"text":"epigenetic alterations"}]}],"extras":null,"metadata":{"first_done_at":1542155446000,"last_updated_at":1542155446000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "estrogen androgens 1 4h cells fixed 10 minutes 1 formaldehyde","annotation":[{"label":["Treatment and conditions"],"points":[{"start":30,"end":60,"text":"fixed 10 minutes 1 formaldehyde"}]},{"label":["Cell type/tissue"],"points":[{"start":24,"end":28,"text":"cells"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":22,"text":"estrogen androgens 1 4h"}]}],"extras":null,"metadata":{"first_done_at":1542140396000,"last_updated_at":1542140396000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols ChIP seq H1299 cells stably transfected empty vector Vector p53 mutant R273H ChIP p53 IgG ChIP seq H1299 cells stably transfected empty vector Vector p53 mutant R273H ChIP p53 IgG","annotation":[{"label":["Treatment and conditions"],"points":[{"start":160,"end":169,"text":"p53 mutant"}]},{"label":["Treatment and conditions"],"points":[{"start":127,"end":151,"text":" transfected empty vector"}]},{"label":["Cell type/tissue"],"points":[{"start":109,"end":119,"text":"H1299 cells"}]},{"label":["Treatment and conditions"],"points":[{"start":70,"end":79,"text":"p53 mutant"}]},{"label":["Treatment and conditions"],"points":[{"start":37,"end":61,"text":" transfected empty vector"}]},{"label":["Cell type/tissue"],"points":[{"start":19,"end":29,"text":"H1299 cells"}]}],"extras":null,"metadata":{"first_done_at":1542139237000,"last_updated_at":1542139237000,"sec_taken":40,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "This single copy chromosome 6 amplified multiple strand displacement converted Illumina sequencing library","annotation":[{"label":["Genotype"],"points":[{"start":4,"end":29,"text":" single copy chromosome 6 "}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":77,"text":"This single copy chromosome 6 amplified multiple strand displacement converted"}]}],"extras":null,"metadata":{"first_done_at":1542156601000,"last_updated_at":1542156601000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Transfection 7 hours performed using Roche X tremegene DNA transfection reagent 0","annotation":[{"label":["Treatment and conditions"],"points":[{"start":59,"end":80,"text":"transfection reagent 0"}]},{"label":["Geographical Location"],"points":[{"start":37,"end":41,"text":"Roche"}]}],"extras":null,"metadata":{"first_done_at":1542159307000,"last_updated_at":1542159307000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Non transformed liver WT C57Bl 6 male mice treated diethylnitrosamine DEN","annotation":[{"label":["Treatment and conditions"],"points":[{"start":43,"end":68,"text":"treated diethylnitrosamine"}]},{"label":["Genotype"],"points":[{"start":22,"end":30,"text":"WT C57Bl "}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":20,"text":"Non transformed liver"}]}],"extras":null,"metadata":{"first_done_at":1542156111000,"last_updated_at":1542156111000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "input Protocols THP 1 cells ATCC TIB 202 cultured RMPI 1640 L glutamine 25mM HEPES Wisent 10 FBS","annotation":[{"label":["Treatment and conditions"],"points":[{"start":41,"end":95,"text":"cultured RMPI 1640 L glutamine 25mM HEPES Wisent 10 FBS"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":26,"text":"input Protocols THP 1 cells"}]}],"extras":null,"metadata":{"first_done_at":1542156138000,"last_updated_at":1542156138000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The libraries prepared using Trueseq library kit Illumina according manufacture recommendations","annotation":null,"extras":null,"metadata":{"first_done_at":1542135707000,"last_updated_at":1542135746000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "2M high salt treatment isolated mitotic chromosomes 5 end tag sequencing protocol","annotation":[{"label":["Genotype"],"points":[{"start":32,"end":60,"text":"mitotic chromosomes 5 end tag"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":80,"text":"2M high salt treatment isolated mitotic chromosomes 5 end tag sequencing protocol"}]}],"extras":null,"metadata":{"first_done_at":1542150554000,"last_updated_at":1542150554000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Organoids derived healthy human induced pluripotent stem cells vitro previously described Gabriel et al","annotation":[{"label":["Geographical Location"],"points":[{"start":79,"end":112,"text":"previously described Gabriel et al"}]},{"label":["Cell type/tissue"],"points":[{"start":62,"end":71,"text":"stem cells"}]}],"extras":null,"metadata":{"first_done_at":1542155142000,"last_updated_at":1542155142000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "RNA 3 organoids infected Brazilian Zika virus strain 3 control organoids isolated subjected high throughput sequencing","annotation":[{"label":["Cell type/tissue"],"points":[{"start":63,"end":81,"text":"organoids isolated "}]},{"label":["Genotype"],"points":[{"start":35,"end":54,"text":"Zika virus strain 3 "}]},{"label":["Geographical Location"],"points":[{"start":25,"end":33,"text":"Brazilian"}]},{"label":["Treatment and conditions"],"points":[{"start":6,"end":23,"text":"organoids infected"}]}],"extras":null,"metadata":{"first_done_at":1542143372000,"last_updated_at":1542143372000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The mixed library amplified sequenced saturation molecules seen preferably least two times","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":89,"text":"The mixed library amplified sequenced saturation molecules seen preferably least two times"}]}],"extras":null,"metadata":{"first_done_at":1542140302000,"last_updated_at":1542140302000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "ChIP seq libraries prepared NEBNext ChIP Seq Library Prep Master Mix Set Illumina NEB E6240S L","annotation":null,"extras":null,"metadata":{"first_done_at":1542158559000,"last_updated_at":1542158559000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Size selection performed 2 agarose gels E Gel Invitrogen G6610 02","annotation":[{"label":["Geographical Location"],"points":[{"start":46,"end":55,"text":"Invitrogen"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":64,"text":"Size selection performed 2 agarose gels E Gel Invitrogen G6610 02"}]}],"extras":null,"metadata":{"first_done_at":1542151254000,"last_updated_at":1542151254000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Libraries barcoded NEBNext Multiplex Oligos Illumina Index Primers Set 1","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":71,"text":"Libraries barcoded NEBNext Multiplex Oligos Illumina Index Primers Set 1"}]}],"extras":null,"metadata":{"first_done_at":1542143581000,"last_updated_at":1542143581000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Neural stem cells cultured proliferation promoting medium Total RNA extracted using Trizol reagent Life Technologies purified RNEasy columns Qiagen three independent samples Sequencing libraries prepared 2 ug total RNA according TruSeq RNA sample preparation v2 protocol Illumina","annotation":null,"extras":null,"metadata":{"first_done_at":1542159342000,"last_updated_at":1542159342000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "5 mouse embryos ventral midbrain dissected using zeiss laser capture microdissection Picopure RNA Isolation Kit Ovation RNA Seq system Nugen","annotation":[{"label":["Treatment and conditions"],"points":[{"start":55,"end":139,"text":"laser capture microdissection Picopure RNA Isolation Kit Ovation RNA Seq system Nugen"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":32,"text":"5 mouse embryos ventral midbrain "}]}],"extras":null,"metadata":{"first_done_at":1542141037000,"last_updated_at":1542141037000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Mouse hearts obtained TAC transverse aortic contraction induce cardiac hypertrophy operated mice 1week Total RNA isolated approximately 450 700mg grinded whole mouse heart using Trizol Reagent Invitrogen following manufacturers instructions","annotation":[{"label":["Geographical Location"],"points":[{"start":203,"end":212,"text":"Invitrogen"}]},{"label":["Treatment and conditions"],"points":[{"start":93,"end":202,"text":"operated mice 1week Total RNA isolated approximately 450 700mg grinded whole mouse heart using Trizol Reagent "}]},{"label":["Disease state"],"points":[{"start":73,"end":91,"text":"cardiac hypertrophy"}]},{"label":["Treatment and conditions"],"points":[{"start":54,"end":71,"text":"contraction induce"}]},{"label":["Cell type/tissue"],"points":[{"start":36,"end":52,"text":"transverse aortic"}]}],"extras":null,"metadata":{"first_done_at":1542137705000,"last_updated_at":1542137705000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols We feeding mice tuber meat either cooked raw","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":53,"text":"Protocols We feeding mice tuber meat either cooked raw"}]}],"extras":null,"metadata":{"first_done_at":1542158462000,"last_updated_at":1542158462000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "In addition cooked food given either restricted certain amount calories calorie un restricted","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":92,"text":"In addition cooked food given either restricted certain amount calories calorie un restricted"}]}],"extras":null,"metadata":{"first_done_at":1542137248000,"last_updated_at":1542137248000,"sec_taken":15,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Mice sacrificed CO2 asphyxiation Full thickness corneas dissected","annotation":[{"label":["Cell type/tissue"],"points":[{"start":43,"end":64,"text":"Full thickness corneas"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":42,"text":"Protocols Mice sacrificed CO2 asphyxiation "}]}],"extras":null,"metadata":{"first_done_at":1542151464000,"last_updated_at":1542151464000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "snap frozen stored 80 C RNA frozen corneas extracted douncing lysis using RNeasy Plus Minikit Qiagen Illumina TruSeqRNA v2 polyA capture","annotation":null,"extras":null,"metadata":{"first_done_at":1542157125000,"last_updated_at":1542157125000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "HL 60 cells seeded 10 ml RPMI 1640 medium supplemented 10 fetal calf serum 0","annotation":[{"label":["Cell type/tissue"],"points":[{"start":58,"end":73,"text":"fetal calf serum"}]},{"label":["Treatment and conditions"],"points":[{"start":12,"end":55,"text":"seeded 10 ml RPMI 1640 medium supplemented 1"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":10,"text":"HL 60 cells"}]}],"extras":null,"metadata":{"first_done_at":1542149792000,"last_updated_at":1542149792000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Serum deprived MCF7 cells treated 10 7 M Estradiol 20ml medium 2 hours 50 minutes","annotation":[{"label":["Treatment and conditions"],"points":[{"start":26,"end":80,"text":"treated 10 7 M Estradiol 20ml medium 2 hours 50 minutes"}]},{"label":["Cell type/tissue"],"points":[{"start":15,"end":24,"text":"MCF7 cells"}]}],"extras":null,"metadata":{"first_done_at":1542151363000,"last_updated_at":1542151363000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "cells fixed with1 PFA processed described Schmidt et al","annotation":[{"label":["Treatment and conditions"],"points":[{"start":12,"end":54,"text":"with1 PFA processed described Schmidt et al"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":4,"text":"cells"}]}],"extras":null,"metadata":{"first_done_at":1542151897000,"last_updated_at":1542151897000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "RNAseq RT PCR experiments performed testis liver material isolated Mus musculus C57BL 6 Mmus","annotation":[{"label":["Genotype"],"points":[{"start":80,"end":86,"text":"C57BL 6"}]},{"label":["Species"],"points":[{"start":67,"end":78,"text":"Mus musculus"}]},{"label":["Cell type/tissue"],"points":[{"start":36,"end":47,"text":"testis liver"}]}],"extras":null,"metadata":{"first_done_at":1542135650000,"last_updated_at":1542135650000,"sec_taken":65,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The following sgRNA targeted loci PCR amplified deep sequencing exon 7 8 Trp53 exon 1 2 PTEN exon 1 VHL","annotation":[{"label":["Genotype"],"points":[{"start":73,"end":102,"text":"Trp53 exon 1 2 PTEN exon 1 VHL"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":46,"text":"The following sgRNA targeted loci PCR amplified"}]}],"extras":null,"metadata":{"first_done_at":1542136996000,"last_updated_at":1542136996000,"sec_taken":78,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "And medical tests like image diagnoses done confirm pulmonary tuberculosis","annotation":[{"label":["Disease state"],"points":[{"start":52,"end":73,"text":"pulmonary tuberculosis"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":50,"text":"And medical tests like image diagnoses done confirm"}]}],"extras":null,"metadata":{"first_done_at":1542151227000,"last_updated_at":1542151227000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols McCoy 24hrs 50 nM miRNA IMPACT protocol Trizol NEBNext Small RNA Sample Prep Set Illumina chemistry","annotation":null,"extras":null,"metadata":{"first_done_at":1542156438000,"last_updated_at":1542156438000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols 4T1 breast tumor cells purchased Caliper Life Sciences product 125669","annotation":[{"label":["Geographical Location"],"points":[{"start":43,"end":63,"text":"Caliper Life Sciences"}]},{"label":["Cell type/tissue"],"points":[{"start":9,"end":31,"text":" 4T1 breast tumor cells"}]}],"extras":null,"metadata":{"first_done_at":1542142129000,"last_updated_at":1542142129000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The samples transfected Luciferase Tomato Replicate exome capture DNA resequencing performed using Agilent Sure Select mouse whole exome solution based capture assay Oligo dT RNA isolated tumor cell line B16F10","annotation":null,"extras":null,"metadata":{"first_done_at":1542154052000,"last_updated_at":1542154055000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols For stable expression either 3xFLAG L3MBTL2 3xFLAG L3MBTL2K675 700R 1","annotation":null,"extras":null,"metadata":{"first_done_at":1542156959000,"last_updated_at":1542156961000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Forty eight hours upon transfection cells selected 1 g ml puromycin 1 g l G 418","annotation":[{"label":["Treatment and conditions"],"points":[{"start":51,"end":78,"text":"1 g ml puromycin 1 g l G 418"}]},{"label":["Cell type/tissue"],"points":[{"start":23,"end":40,"text":"transfection cells"}]}],"extras":null,"metadata":{"first_done_at":1542135585000,"last_updated_at":1542135585000,"sec_taken":54,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "ChIP Seq experiments performed using OneDay ChIP kit Diagenode accordance manufacturer instructions","annotation":[{"label":["Geographical Location"],"points":[{"start":74,"end":85,"text":"manufacturer"}]},{"label":["teat"],"points":[{"start":0,"end":61,"text":"ChIP Seq experiments performed using OneDay ChIP kit Diagenode"}]}],"extras":null,"metadata":{"first_done_at":1542143630000,"last_updated_at":1542143630000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "cells harvested 24 hours Following infection total RNA isolated using QIAGEN RNeasy kit following manufacturer instructions Following manufacturer Ribo Zero Human Mouse Rat kit Epicentre","annotation":[{"label":["Geographical Location"],"points":[{"start":134,"end":145,"text":"manufacturer"}]},{"label":["Geographical Location"],"points":[{"start":98,"end":109,"text":"manufacturer"}]},{"label":["Treatment and conditions"],"points":[{"start":16,"end":44,"text":"24 hours Following infection "}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":14,"text":"cells harvested"}]}],"extras":null,"metadata":{"first_done_at":1542148714000,"last_updated_at":1542148720000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols cutaneous biopsy performed fibroblasts culture MEM medium supplementend 10 FBS","annotation":[{"label":["Treatment and conditions"],"points":[{"start":49,"end":87,"text":"culture MEM medium supplementend 10 FBS"}]},{"label":["Cell type/tissue"],"points":[{"start":37,"end":48,"text":"fibroblasts "}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":35,"text":"Protocols cutaneous biopsy performed"}]}],"extras":null,"metadata":{"first_done_at":1542140942000,"last_updated_at":1542140942000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "DNA extracted using Qiagen Kit The fragment ends repaired","annotation":null,"extras":null,"metadata":{"first_done_at":1542158479000,"last_updated_at":1542158479000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "A bases added ends DNA fragments adapters ligated fragments","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":58,"text":"A bases added ends DNA fragments adapters ligated fragments"}]}],"extras":null,"metadata":{"first_done_at":1542149739000,"last_updated_at":1542149739000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The adapter ligated library amplified using 4 6 cycles PCR","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":57,"text":"The adapter ligated library amplified using 4 6 cycles PCR"}]}],"extras":null,"metadata":{"first_done_at":1542151321000,"last_updated_at":1542151321000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "500 nanograms sample library hybridized SureSelect biotinylated RNA library 24 hours","annotation":null,"extras":null,"metadata":{"first_done_at":1542158597000,"last_updated_at":1542158597000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Osteosarcoma derived cybrid 143B cell lines carrying mutation m3571insC mtND1 heteroplasmy 78 sequenced using 454 platform","annotation":[{"label":["Genotype"],"points":[{"start":44,"end":92,"text":"carrying mutation m3571insC mtND1 heteroplasmy 78"}]},{"label":["Cell type/tissue"],"points":[{"start":28,"end":42,"text":"143B cell lines"}]}],"extras":null,"metadata":{"first_done_at":1542150434000,"last_updated_at":1542150434000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Genomic DNA extracted peripheral blood Qiagen columns QIAamp DNA minikit","annotation":[{"label":["Cell type/tissue"],"points":[{"start":32,"end":47,"text":"peripheral blood"}]},{"label":["Treatment and conditions"],"points":[{"start":10,"end":81,"text":"Genomic DNA extracted peripheral blood Qiagen columns QIAamp DNA minikit"}]}],"extras":null,"metadata":{"first_done_at":1542149368000,"last_updated_at":1542149368000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Germany according manufacturer instructions Library preparation sequencing runs performed according manufacturer procedure Illumina","annotation":[{"label":["Geographical Location"],"points":[{"start":0,"end":6,"text":"Germany"}]}],"extras":null,"metadata":{"first_done_at":1542141575000,"last_updated_at":1542141575000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Samples collected 350l RLT buffer containing 1 B mecaptoethanol 10","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":75,"text":"Protocols Samples collected 350l RLT buffer containing 1 B mecaptoethanol 10"}]}],"extras":null,"metadata":{"first_done_at":1542138961000,"last_updated_at":1542138961000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "non essential amino acids penicillin streptomycin Total RNA extracted Macherey Nagel Nucleospin RNA II kit","annotation":[{"label":["Disease state"],"points":[{"start":37,"end":48,"text":"streptomycin"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":35,"text":"non essential amino acids penicillin"}]}],"extras":null,"metadata":{"first_done_at":1542142882000,"last_updated_at":1542142882000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "HEK293 cells transfected Control REST RNA interfeerence using lipofectmain 24 hours","annotation":[{"label":["Genotype"],"points":[{"start":13,"end":41,"text":"transfected Control REST RNA "}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":11,"text":"HEK293 cells"}]}],"extras":null,"metadata":{"first_done_at":1542141424000,"last_updated_at":1542141424000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Cells exposed normoxic 21 oxygen hypoxic 1 oxygen pre conditioned media 24 hours transfection","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":92,"text":"Cells exposed normoxic 21 oxygen hypoxic 1 oxygen pre conditioned media 24 hours transfection"}]}],"extras":null,"metadata":{"first_done_at":1542155378000,"last_updated_at":1542155378000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "For library construction illumina TruSeq v2 mRNA kit utilized poly A RNA enriched total RNA samples","annotation":null,"extras":null,"metadata":{"first_done_at":1542151647000,"last_updated_at":1542151647000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Libraries quantified pooling sequencing using Kapa Biosystems qPCR quantitation kit","annotation":[{"label":["Geographical Location"],"points":[{"start":46,"end":60,"text":"Kapa Biosystems"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":82,"text":"Libraries quantified pooling sequencing using Kapa Biosystems qPCR quantitation kit"}]}],"extras":null,"metadata":{"first_done_at":1542156826000,"last_updated_at":1542156826000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Samples sequenced using Ion Torrent PGM custom Ampliseq panel","annotation":null,"extras":null,"metadata":{"first_done_at":1542159155000,"last_updated_at":1542159155000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Large RNA removed small RNA fraction using RNeasy Mini Kit Qiagen","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":64,"text":"Large RNA removed small RNA fraction using RNeasy Mini Kit Qiagen"}]}],"extras":null,"metadata":{"first_done_at":1542136542000,"last_updated_at":1542136542000,"sec_taken":290,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Akata cells derived EBV genome positive Brkitt lymphoma Japanese patient","annotation":null,"extras":null,"metadata":{"first_done_at":1542154458000,"last_updated_at":1542154461000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Peripheral blood samples collected visit DNA extracted stored 80oC sequencing Standard library construction","annotation":[{"label":["Treatment and conditions"],"points":[{"start":51,"end":116,"text":"DNA extracted stored 80oC sequencing Standard library construction"}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":33,"text":"Peripheral blood samples"}]}],"extras":null,"metadata":{"first_done_at":1542138193000,"last_updated_at":1542138193000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Following iCLIP protocol retrieval protein bound RNAs construction Illumina compatible libraries done described Huppertz et al","annotation":null,"extras":null,"metadata":{"first_done_at":1542159391000,"last_updated_at":1542159391000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Transcriptional profiling SMARTer Seq performed RNA material CD48 LSK cells mouse mi15388 08 Sbds mutant mesenchymal stem cells","annotation":[{"label":["Cell type/tissue"],"points":[{"start":105,"end":126,"text":"mesenchymal stem cells"}]},{"label":["Genotype"],"points":[{"start":93,"end":103,"text":"Sbds mutant"}]},{"label":["Cell type/tissue"],"points":[{"start":61,"end":74,"text":"CD48 LSK cells"}]}],"extras":null,"metadata":{"first_done_at":1542159241000,"last_updated_at":1542159241000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "To evaluate DNA cleavage efficiency Cas9 delivered protein complexed either EMX sgRNA liposomes mouse cochlea vivo","annotation":[{"label":["Cell type/tissue"],"points":[{"start":96,"end":108,"text":"mouse cochlea"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":84,"text":"To evaluate DNA cleavage efficiency Cas9 delivered protein complexed either EMX sgRNA"}]}],"extras":null,"metadata":{"first_done_at":1542139012000,"last_updated_at":1542139012000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Total RNA obtained 2 male 2 female IgMb negative B cells","annotation":[{"label":["Cell type/tissue"],"points":[{"start":49,"end":55,"text":"B cells"}]},{"label":["Genotype"],"points":[{"start":35,"end":47,"text":"IgMb negative"}]}],"extras":null,"metadata":{"first_done_at":1542157575000,"last_updated_at":1542157575000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "BAFF delta BAFF Tg mice C57BL 6 background previously described Gavin et al","annotation":[{"label":["Genotype"],"points":[{"start":0,"end":41,"text":"BAFF delta BAFF Tg mice C57BL 6 background"}]}],"extras":null,"metadata":{"first_done_at":1542142920000,"last_updated_at":1542142920000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "BAFF 3H9 delta BAFF 3H9 double Tg mice generated breeding homozygous BAFF delta BAFF Tg 3H9 mice","annotation":[{"label":["Genotype"],"points":[{"start":0,"end":29,"text":"BAFF 3H9 delta BAFF 3H9 double"}]}],"extras":null,"metadata":{"first_done_at":1542157522000,"last_updated_at":1542157522000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "cultures changed phenol red free MEM medium 5 charcoal dextran treated FBS","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":73,"text":"cultures changed phenol red free MEM medium 5 charcoal dextran treated FBS"}]}],"extras":null,"metadata":{"first_done_at":1542151914000,"last_updated_at":1542151914000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Illumina TruSeq RNA Sample Prep Kit used 1 ug total RNA construction sequencing libraries","annotation":null,"extras":null,"metadata":{"first_done_at":1542155190000,"last_updated_at":1542155190000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "resting B cells stimulated LPS 50 mcg ml IL 4 2","annotation":[{"label":["Treatment and conditions"],"points":[{"start":15,"end":46,"text":" stimulated LPS 50 mcg ml IL 4 2"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":14,"text":"resting B cells"}]}],"extras":null,"metadata":{"first_done_at":1542143685000,"last_updated_at":1542143685000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "RNA extracted using PureLinkTM RNA Mini kit Ambion RNA libraries constructed using Illumina TruSeq Stranded mRNA kit","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":115,"text":"RNA extracted using PureLinkTM RNA Mini kit Ambion RNA libraries constructed using Illumina TruSeq Stranded mRNA kit"}]}],"extras":null,"metadata":{"first_done_at":1542151438000,"last_updated_at":1542151438000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Cardiomyocytes isolated hearts end perfusion collagenase collagenase type II","annotation":[{"label":["Genotype"],"points":[{"start":57,"end":75,"text":"collagenase type II"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":54,"text":"Cardiomyocytes isolated hearts end perfusion collagenas"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":22,"text":"Cardiomyocytes isolated"}]}],"extras":null,"metadata":{"first_done_at":1542159211000,"last_updated_at":1542159211000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Immunoprecipitate DNA Chromatin Immunoprecipitaion assay ChIP using antibody H3K9ac","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":82,"text":"Immunoprecipitate DNA Chromatin Immunoprecipitaion assay ChIP using antibody H3K9ac"}]}],"extras":null,"metadata":{"first_done_at":1542149691000,"last_updated_at":1542149691000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols mouse Brains obtained 8 weeks old mice Jackson lab maine USA total RNA extraction using trizol per manufacturer instructions","annotation":[{"label":["Geographical Location"],"points":[{"start":49,"end":59,"text":"Jackson lab"}]},{"label":["Treatment and conditions"],"points":[{"start":23,"end":133,"text":"obtained 8 weeks old mice Jackson lab maine USA total RNA extraction using trizol per manufacturer instructions"}]},{"label":["Cell type/tissue"],"points":[{"start":10,"end":21,"text":"mouse Brains"}]}],"extras":null,"metadata":{"first_done_at":1542143249000,"last_updated_at":1542143249000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Approximately 1 g RNA used sequence RNA seq library","annotation":null,"extras":null,"metadata":{"first_done_at":1542157224000,"last_updated_at":1542157224000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "CHM1htert well characterized haploid cell line derived hydatidiform mole","annotation":[{"label":["Cell type/tissue"],"points":[{"start":37,"end":71,"text":"cell line derived hydatidiform mole"}]},{"label":["Genotype"],"points":[{"start":0,"end":36,"text":"CHM1htert well characterized haploid "}]}],"extras":null,"metadata":{"first_done_at":1542140242000,"last_updated_at":1542140242000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "sequencing miRNA wild type diseased mouse hearts using PCR based bar codes","annotation":[{"label":["Treatment and conditions"],"points":[{"start":49,"end":73,"text":"using PCR based bar codes"}]},{"label":["Cell type/tissue"],"points":[{"start":36,"end":47,"text":"mouse hearts"}]},{"label":["Genotype"],"points":[{"start":17,"end":34,"text":"wild type diseased"}]}],"extras":null,"metadata":{"first_done_at":1542136632000,"last_updated_at":1542136632000,"sec_taken":41,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Samples cardiac left ventricle taken three wild type mouse","annotation":[{"label":["Genotype"],"points":[{"start":43,"end":57,"text":"wild type mouse"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":29,"text":"Samples cardiac left ventricle"}]}],"extras":null,"metadata":{"first_done_at":1542156551000,"last_updated_at":1542156551000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Samples cardiac left ventricle also taken three diseased mouse Hypertrophic cardiomyopathy","annotation":[{"label":["Disease state"],"points":[{"start":63,"end":89,"text":"Hypertrophic cardiomyopathy"}]},{"label":["Cell type/tissue"],"points":[{"start":7,"end":29,"text":" cardiac left ventricle"}]}],"extras":null,"metadata":{"first_done_at":1542156258000,"last_updated_at":1542156258000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "miRNA extracted eight samples using AMbion mirVana miRNA Isolation Kit Ambion AM1561","annotation":null,"extras":null,"metadata":{"first_done_at":1542159630000,"last_updated_at":1542159630000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "The eight libraries sequenced together using PCR based bar codes one lane illumina GAIIx instrument","annotation":null,"extras":null,"metadata":{"first_done_at":1542153100000,"last_updated_at":1542153100000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "ESC derived DE PPs sorted CD184 CD117 CD24high CD49 flow","annotation":[{"label":["Genotype"],"points":[{"start":26,"end":36,"text":"CD184 CD117"}]},{"label":["Treatment and conditions"],"points":[{"start":19,"end":55,"text":"sorted CD184 CD117 CD24high CD49 flow"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":11,"text":"ESC derived "}]}],"extras":null,"metadata":{"first_done_at":1542138555000,"last_updated_at":1542138555000,"sec_taken":73,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Male 9 week old wild type mice sacrified lungs sampled total RNA isolation","annotation":[{"label":["Cell type/tissue"],"points":[{"start":41,"end":45,"text":"lungs"}]},{"label":["Treatment and conditions"],"points":[{"start":31,"end":73,"text":"sacrified lungs sampled total RNA isolation"}]},{"label":["Genotype"],"points":[{"start":16,"end":24,"text":"wild type"}]}],"extras":null,"metadata":{"first_done_at":1542158786000,"last_updated_at":1542158786000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "We picked 144 fosmid clones loci predicted copy number structural variations deletions","annotation":[{"label":["Genotype"],"points":[{"start":43,"end":85,"text":"copy number structural variations deletions"}]},{"label":["Treatment and conditions"],"points":[{"start":10,"end":26,"text":"144 fosmid clones"}]}],"extras":null,"metadata":{"first_done_at":1542142070000,"last_updated_at":1542142070000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "sequenced Illumina GAII two lanes paired 76 bp reads 9 bp index read","annotation":null,"extras":null,"metadata":{"first_done_at":1542149448000,"last_updated_at":1542149448000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "This sample obtained C3H HeN mice Charles Rivers Lab","annotation":null,"extras":null,"metadata":{"first_done_at":1542140455000,"last_updated_at":1542140469000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Induced pluripotent stem cell iPS line derived mouse embryonic fibroblasts MEF using established polycistronic lentivirus containing three transcription factors","annotation":[{"label":["Treatment and conditions"],"points":[{"start":79,"end":159,"text":"using established polycistronic lentivirus containing three transcription factors"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":37,"text":"Induced pluripotent stem cell iPS line"}]}],"extras":null,"metadata":{"first_done_at":1542149403000,"last_updated_at":1542149403000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Dietary intervention probiotic Bifidobacterium modulates dominant bacterial taxa enterotype dependent fashion normalizes butyrate levels gut healthy adults","annotation":[{"label":["Disease state"],"points":[{"start":141,"end":154,"text":"healthy adults"}]},{"label":["Species"],"points":[{"start":66,"end":90,"text":"bacterial taxa enterotype"}]},{"label":["Genotype"],"points":[{"start":21,"end":29,"text":"probiotic"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":19,"text":"Dietary intervention"}]}],"extras":null,"metadata":{"first_done_at":1542157103000,"last_updated_at":1542157103000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "pt74 HC set1 Patient 74 Heavy Chain Variable SRR275711","annotation":[{"label":["Genotype"],"points":[{"start":5,"end":11,"text":"HC set1"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":43,"text":"pt74 HC set1 Patient 74 Heavy Chain Variable"}]}],"extras":null,"metadata":{"first_done_at":1542158502000,"last_updated_at":1542158502000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "pt74 HC set2 Patient 74 Heavy Chain Variable SRR277211","annotation":null,"extras":null,"metadata":{"first_done_at":1542141270000,"last_updated_at":1542141344000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "expression levels mRNAs total transcripts captured RIP TIA1 antibody TIA1 RIP analyzed","annotation":[{"label":["Genotype"],"points":[{"start":42,"end":58,"text":"captured RIP TIA1"}]},{"label":["Treatment and conditions"],"points":[{"start":17,"end":40,"text":" mRNAs total transcripts"}]}],"extras":null,"metadata":{"first_done_at":1542142409000,"last_updated_at":1542142414000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "SUM 44PE cells cultured estrogen free conditions fixed chromatin immunoprecipitation performed anti estrogen receptor alpha antibody followed 35bp single end Illumina sequencing","annotation":[{"label":["Genotype"],"points":[{"start":95,"end":116,"text":"anti estrogen receptor"}]},{"label":["Treatment and conditions"],"points":[{"start":14,"end":83,"text":" cultured estrogen free conditions fixed chromatin immunoprecipitation"}]},{"label":["Cell type/tissue"],"points":[{"start":0,"end":13,"text":"SUM 44PE cells"}]}],"extras":null,"metadata":{"first_done_at":1542139654000,"last_updated_at":1542139654000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "We make reads available express consent original lead author serve supporting material forth coming publication","annotation":null,"extras":null,"metadata":{"first_done_at":1542159525000,"last_updated_at":1542159525000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Rif1F F Rosa26Cre ERT2 pMEF synchronized G1 treated tamoxifen activate Cre induce deletion pMEF Rif1 ko","annotation":[{"label":["Genotype"],"points":[{"start":62,"end":102,"text":"activate Cre induce deletion pMEF Rif1 ko"}]},{"label":["Treatment and conditions"],"points":[{"start":28,"end":60,"text":"synchronized G1 treated tamoxifen"}]},{"label":["Genotype"],"points":[{"start":0,"end":26,"text":"Rif1F F Rosa26Cre ERT2 pMEF"}]}],"extras":null,"metadata":{"first_done_at":1542150295000,"last_updated_at":1542150295000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Rif1 Rosa26Cre ERT2 pMEF treated parallel pMEF Rif1wt Primary restriction digest performed incubation HindIII","annotation":[{"label":["Treatment and conditions"],"points":[{"start":20,"end":108,"text":"pMEF treated parallel pMEF Rif1wt Primary restriction digest performed incubation HindIII"}]},{"label":["Genotype"],"points":[{"start":0,"end":18,"text":"Rif1 Rosa26Cre ERT2"}]}],"extras":null,"metadata":{"first_done_at":1542137948000,"last_updated_at":1542137948000,"sec_taken":36,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "BAM file SNPforID reads created Illumina sequencing This BAM file contains mapped subreads 9947A sample","annotation":null,"extras":null,"metadata":{"first_done_at":1542157799000,"last_updated_at":1542157799000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Murine vitro Th2 differentiation using Naive CD4 CD62L cells presence IL4 plate coated anti CD3 anti CD28 antibody lysis Fluidigm C1 according single cell mRNA library preparation manual Using C1TM Single Cell Auto Prep System Generate mRNA Single Cells Libraries Sequencing RT using SMARTer chemistry","annotation":[{"label":["Cell type/tissue"],"points":[{"start":10,"end":25,"text":"Murine vitro Th2"}]},{"label":["Treatment and conditions"],"points":[{"start":0,"end":310,"text":"Protocols Murine vitro Th2 differentiation using Naive CD4 CD62L cells presence IL4 plate coated anti CD3 anti CD28 antibody lysis Fluidigm C1 according single cell mRNA library preparation manual Using C1TM Single Cell Auto Prep System Generate mRNA Single Cells Libraries Sequencing RT using SMARTer chemistry"}]}],"extras":null,"metadata":{"first_done_at":1542156305000,"last_updated_at":1542156305000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "according manual Using C1TM Single Cell Auto Prep System Generate mRNA Single Cells Libraries Sequencing","annotation":[{"label":["Treatment and conditions"],"points":[{"start":45,"end":103,"text":"Prep System Generate mRNA Single Cells Libraries Sequencing"}]}],"extras":null,"metadata":{"first_done_at":1542138252000,"last_updated_at":1542138252000,"sec_taken":0,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "2013 applying negative pressure glass micropipette Cadwell et al","annotation":[{"label":["Treatment and conditions"],"points":[{"start":5,"end":30,"text":"applying negative pressure"}]}],"extras":null,"metadata":{"first_done_at":1542135677000,"last_updated_at":1542135677000,"sec_taken":26,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
{"content": "Protocols Total RNA extracted TRIzol reagent Invitrogen according manufacturers protocol","annotation":[{"label":["Treatment and conditions"],"points":[{"start":0,"end":87,"text":"Protocols Total RNA extracted TRIzol reagent Invitrogen according manufacturers protocol"}]}],"extras":null,"metadata":{"first_done_at":1542139143000,"last_updated_at":1542139143000,"sec_taken":15,"last_updated_by":"EEOBDlEO48T6gzo0KHvT0IkqZnn2","status":"done","evaluation":"NONE"}}
